Back to GetFilings.com
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
( X ) ANNUAL REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT
OF 1934: For the fiscal year ended September 30, 2002
( ) TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934:
For the transition period from _________________ to ______________
Commission File Number: 0-13265
UCI MEDICAL AFFILIATES, INC.
(Name of Registrant as Specified in its Charter)
Delaware 59-2225346
(State or Other Jurisdiction of
Incorporation or Organization) (IRS Employer Identification Number)
4416 Forest Drive, Columbia, SC 29206
(Address of Principal Executive Offices) (Zip Code)
(803) 782-4278
(Registrant's Telephone Number, Including Area Code)
Securities to be registered pursuant to Section 12(b) of the Act: None
Securities to be registered pursuant to Section 12(g) of the Act: Common Stock,
$.05 par value
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding twelve months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to the filing
requirements for the past 90 days. Yes X No
Indicate by check mark if the disclosure of delinquent filers pursuant to Item
405 of regulation S-K is not contained herein, and will not be contained, to the
best of the registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. ( X )
Indicate by check mark whether the registrant is an accelerated filer (as
defined in Exchange Act Rule 12b-2) Yes ____ No X
The aggregate market value of voting stock held by non-affiliates of the
registrant on October 31, 2002 was approximately $1,878,858.* The registrant has
no non-voting common equity.
APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING
THE PRECEDING FIVE YEARS
Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Section 12, 13, or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court. Yes X No
APPLICABLE ONLY TO CORPORATE REGISTRANTS
The number of shares outstanding of the registrant's common stock, $.05 par
value, was 9,650,515 at December 16, 2002.
DOCUMENTS INCORPORATED BY REFERENCE NONE
* Calculated by excluding all shares held by officers, directors and controlling
shareholders of registrant without conceding that all such persons are
affiliates of registrant for purposes of the federal securities laws.
UCI MEDICAL AFFILIATES, INC.
INDEX TO FORM 10-K
PART I PAGE
Item 1. Business 3
Item 2. Properties 9
Item 3. Legal Proceedings 10
Item 4. Submission of Matters to a Vote of Security Holders 10
PART II
Item 5. Market for Registrant's Common Equity and Related Stockholder Matters 11
Item 6. Selected Financial Data 11
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 12
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 18
Item 8. Financial Statements and Supplementary Data 18
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 18
PART III
Item 10. Directors and Executive Officers of the Registrant 19
Item 11. Executive Compensation 21
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
24
Item 13. Certain Relationships and Related Transactions 25
Item 14. Controls and Procedures 27
Item 15. Exhibits, Financial Statement Schedules, and Reports on Form 8-K 28
Advisory Note Regarding Forward-Looking Statements
Certain of the statements contained in this Report on Form 10-K that are not
historical facts are forward-looking statements subject to the safe harbor
created by the Private Securities Litigation Reform Act of 1995. We caution
readers of this Annual Report on Form 10-K that such forward-looking statements
involve known and unknown risks, uncertainties and other factors that may cause
our actual results, performance or achievements to be materially different from
those expressed or implied by such forward-looking statements. Although our
management believes that their expectations of future performance are based on
reasonable assumptions within the bounds of their knowledge of their business
and operations, we have no assurance that actual results will not differ
materially from their expectations. Factors that could cause actual results to
differ from expectations include, among other things, (1) the difficulty in
controlling our costs of providing healthcare and administering our network of
centers; (2) the possible negative effects from changes in reimbursement and
capitation payment levels and payment practices by insurance companies,
healthcare plans, government payors and other payment sources; (3) the
difficulty of attracting primary care physicians; (4) the increasing competition
for patients among healthcare providers; (5) possible government regulations
negatively impacting our existing organizational structure; (6) the possible
negative effects of prospective healthcare reform; (7) the challenges and
uncertainties in the implementation of our expansion and development strategy;
(8) the dependence on key personnel; (9) adverse conditions in the stock market,
the public debt market, and other capital markets (including changes in interest
rate conditions); (10) the strength of the United States economy in general and
the strength of the local economies in which we conduct operations may be
different than expected resulting in, among other things, a reduced demand for
practice management services; (11) the demand for our products and services;
(12) technological changes; (13) the ability to increase market share; (14) the
adequacy of expense projections and estimates of impairment loss; (15) the
impact of change in accounting policies by the Securities and Exchange
Commission; (16) unanticipated regulatory or judicial proceedings; (17) the
impact on our business, as well as on the risks set forth above, of various
domestic or international military or terrorist activities or conflicts; (18)
other factors described in this report and in our other reports filed with the
Securities and Exchange Commission; and (19) our success at managing the risks
involved in the foregoing.
PART I
Item 1. Business
General
UCI Medical Affiliates, Inc. (UCI) is a Delaware corporation incorporated on
August 25, 1982. Operating through its wholly-owned subsidiaries, UCI Medical
Affiliates of South Carolina, Inc. (UCI-SC) and UCI Medical Affiliates of
Georgia, Inc. ("UCI-GA"), UCI provides nonmedical management and administrative
services for a network of 36 freestanding medical centers, 34 of which are
located throughout South Carolina and two are located in Knoxville, Tennessee
(29 operating as Doctorss.s Care in South Carolina, one as Doctor's Care in
Knoxville, Tennessee, five as Progressive Physical Therapy Services in South
Carolina, and one as Progressive Physical Therapy Services in Knoxville,
Tennessee). We refer to these 36 medical centers as the "centers" throughout
this report.
Organizational Structure
Federal law and the laws of South Carolina generally specify who may practice
medicine and limit the scope of relationships between medical practitioners and
other parties. Under such laws, UCI, UCI-SC and UCI-GA are prohibited from
practicing medicine or exercising control over the provision of medical
services. In order to comply with such laws, all medical services at the centers
are provided by or under the supervision of Doctorss.s Care, P.A. or Doctor's
Care of Tennessee, P.C. (collectively the "P.A.'s"), each of which has
contracted with UCI-SC or UCI-GA, as applicable, to be the sole provider of all
non-medical direction and supervision of the centers operating in its respective
state of organization. We refer to the P.A.'s, UCI, UCI-SC, and UCI-GA
collectively throughout this report as "we", "us", and "our." Each P.A. is
organized so that all physician services are offered by the physicians who are
employed by the P.A. Neither UCI, UCI-SC nor UCI-GA employ practicing physicians
as practitioners, exert control over their decisions regarding medical care or
represent to the public that it offers medical services.
UCI-SC and UCI-GA have entered into Administrative Services Agreements with the
P.A.'s pursuant to which UCI-SC and UCI-GA perform all non-medical management of
the P.A.'s and have exclusive authority over all aspects of the business of the
P.A.'s (other than those directly related to the provision of patient medical
services or as otherwise prohibited by state law). The non-medical management
provided by UCI-SC and UCI-GA includes, among other functions, treasury and
capital planning, financial reporting and accounting, pricing decisions, patient
acceptance policies, setting office hours, contracting with third party payors
and all administrative services. UCI-SC and UCI-GA provide all of the resources
(systems, procedures, and staffing) to bill third party payors or patients, and
provide all of the resources (systems, procedures, and staffing) for cash
collection and management of accounts receivables, including custody of the
lockbox where cash receipts are deposited. From the cash receipts, UCI-SC and
UCI-GA pay all physician salaries, operating costs of the centers and operating
costs of UCI-SC and UCI-GA. Compensation guidelines for the licensed medical
professionals at the P.A.'s are set by UCI-SC and UCI-GA, and UCI-SC and UCI-GA
establish guidelines for establishing, selecting, hiring and firing the licensed
medical professionals. UCI-SC and UCI-GA also negotiate and execute
substantially all of the provider contracts with third party payors. Neither
UCI-SC nor UCI-GA loans or otherwise advances funds to any P.A. for any
purposes.
The P.A.'s and UCI-SC share a common management team. In each case, the same
individuals serve in the same executive offices of each entity.
UCI-SC and UCI-GA believe that the services they provide to the P.A.'s do not
constitute the practice of medicine under applicable laws. Nevertheless, because
of the uniqueness of the structure of the relationships described above, many
aspects of our business operations have not been the subject of state or federal
regulatory interpretation. We have no assurance that a review of our business by
the courts or regulatory authorities will not result in a determination that
could adversely affect our operations or that the health care regulatory
environment will not change so as to restrict our existing operations or future
expansion.
Chapter 11 Bankruptcy Filing
On November 2, 2001, we filed a voluntary petition for reorganization under
Chapter 11 of the United States Bankruptcy Code (the "Bankruptcy Code") in the
United States Bankruptcy Court for the District of South Carolina (the
"Bankruptcy Court"). We remained in possession of our properties and assets, and
our management continued to operate our business as debtors-in-possession. As
debtors-in-possession, we were authorized to continue to operate our businesses,
but we were not allowed to engage in transactions outside the ordinary course of
business without the approval, after notice and an opportunity for a hearing, of
the Bankruptcy Court. Pursuant to the automatic stay provisions of the
Bankruptcy Code, all actions to collect pre-petition indebtedness from us, as
well as most other pending litigation against us, were stayed. In addition, as
debtors-in-possession, we had the right, subject to the approval of the
Bankruptcy Court and certain other conditions, to assume or reject any
pre-petition executory contracts or unexpired leases.
The Bankruptcy Court approved payment of certain pre-petition liabilities, such
as employee wages and benefits and settlement of certain trade payable claims.
In addition, the Bankruptcy Court allowed for the retention of legal and
financial professionals to advise in the bankruptcy proceedings.
Each of our Plans of Reorganization was confirmed by the Court by August 8,
2002, and we have, therefore, emerged from the Chapter 11 protection of the
Court.
The Centers
The centers are staffed by licensed physicians, physical therapists, other
healthcare providers and administrative support staff. The medical support staff
includes licensed nurses, certified medical assistants, laboratory technicians
and x-ray technicians.
The centers typically are open for extended hours (weekends and evenings) and
out-patient care only. When hospitalization or specialty care is needed,
referrals to appropriate specialists are made.
Our centers are broadly distributed throughout the state of South Carolina, and
two are in Knoxville, Tennessee. Fifteen primary care centers are in the
Columbia region (including three physical therapy offices), seven in the
Charleston region (including one physical therapy office), four in the Myrtle
Beach region, one in the Aiken region, seven in the Greenville-Spartanburg
region (including one physical therapy office) and two in Knoxville, Tennessee
(including one physical therapy office).
Medical Services Provided at the Centers
Our centers offer out-patient medical care, without appointment, for treatment
of acute, episodic and some chronic medical problems. The centers provide a
broad range of medical services that would generally be classified as within the
scope of family practice, primary care and occupational medicine. The medical
services are provided by licensed medical providers, nurses and auxiliary
support personnel. The services provided at the centers include, but are not
limited to, the following:
o Routine care of general medical problems, including colds, flu, ear
infections, hypertension, asthma, pneumonia and other conditions typically
treated by primary care providers;
o Treatment of injuries, such as simple fractures, dislocations, sprains,
bruises and cuts;
o Minor surgery, including suturing of lacerations and removal of cysts and
foreign bodies;
o Diagnostic tests, such as x-rays, electrocardiograms, complete blood
counts and urinalyses; and
o Occupational and industrial medical services, including drug testing,
workers' compensation cases and physical examinations.
At any of the centers, a patient with a life-threatening condition would be
evaluated by the physician, stabilized and immediately referred to a nearby
hospital.
Patient Charges and Payments
The fees charged to a patient are determined by the nature of medical services
rendered. Our management believes that the charges at our centers are
significantly lower than the charges of hospital emergency departments and are
generally competitive with the charges of local physicians and other providers
in the area.
Our centers accept payment from a wide range of sources. These include patient
payments at time of service (by cash, check or credit card), patient billing and
assignment of insurance benefits (including Blue Cross Blue Shield, Workers'
Compensation and other private insurance). Managed care billings represent the
most significant source of revenues. We also provide services for members of the
four largest health maintenance organizations (HMOs) operating in South Carolina
- - Companion HealthCare Corporation, HMO Blue, Cigna/HealthSource South Carolina,
Inc., and Carolina Care Plan.
The following table breaks out our approximate revenue and patient visits by
revenue source for fiscal year 2002:
Percent of Percent of Revenue
Payor Patient Visits
- ------------------------------- ------------------- -------------------
16 14
Patient Pay
11 6
Employer Paid
9 9
HMO
11 14
Workers Compensation
10 7
Medicare/Medicaid
40 46
Managed Care Insurance
3 4
Other (Commercial Indemnity,
Champus, etc.)
In accordance with the Administrative Services Agreements described above,
UCI-SC and UCI-GA, as the agents for the P.A.'s, process all payments for the
P.A.'s. When payments for the P.A.'s are received, they are deposited in
accounts owned by each P.A. and are automatically transferred to lockbox
accounts owned by UCI-SC and UCI-GA. In no event are the physicians entitled to
receive such payments. The patient mix in no way affects our management service
fees per the Administrative Services Agreements.
Reimbursement Arrangements
Medical services traditionally have been provided on a fee-for-service basis
with insurance companies assuming responsibility for paying all or a portion of
such fees. The increase in medical costs under traditional indemnity health care
plans has been caused by a number of factors. These factors include: (i) the
lack of incentives on the part of health care providers to deliver
cost-effective medical care; (ii) the absence of controls over the utilization
of costly specialty care physicians and hospitals; (iii) a growing and aging
population that requires increased health care expenditures; and (iv) the
expense involved with the introduction and use of advanced pharmaceuticals and
medical technology.
As a result of escalating health care costs, employers, insurers and
governmental entities all have sought cost-effective approaches to the delivery
of and payment for quality health care services. HMOs and other managed health
care organizations have emerged as integral components in this effort. HMOs
enroll members by entering into contracts with employer groups or directly with
individuals to provide a broad range of health care services for a capitation
payment or a discounted fee-for-service schedule, with minimal or no deductibles
or co-payments required of the members. HMOs, in turn, contract with health care
providers like the Company to administer medical care to HMO members. These
contracts provide for payment to the Company on a discounted fee-for-service
basis.
We currently do not provide any services on a capitated basis.
Certain third party payors are studying various alternatives for reducing
medical costs, some of which, if implemented, could affect our reimbursement
levels. Our management cannot predict whether changes in present reimbursement
methods or proposed future modifications in reimbursement methods will affect
payments for services provided by the centers and, if so, whether they will have
an adverse impact upon our business.
Competition and Marketing
All of our centers face competition, in varying degrees, from hospital emergency
rooms, private doctor's offices, other competing freestanding medical centers
and physical therapy offices. Some of these providers have financial resources
that are greater than our resources. In addition, traditional sources of medical
services, such as hospital emergency rooms and private physicians, have had, in
the past, a higher degree of recognition and acceptance by patients than centers
such ours. Our centers compete on the basis of accessibility, including evening
and weekend hours, a no-appointment policy, the attractiveness of our state-wide
network to large employers and third party payors, and a competitive fee
schedule. In an effort to offset the competition's community recognition, we
have substantial marketing efforts. Regional marketing representatives have been
added, focused promotional material has been developed and a newsletter for
employers promoting our activities has been initiated.
Government Regulation
As participants in the health care industry, our operations and relationships
are subject to extensive and increasing regulation by a number of governmental
entities at the federal, state and local levels.
Limitations on the Corporate Practice of Medicine
Federal law and the laws of many states, including Georgia, South Carolina and
Tennessee, generally specify who may practice medicine and limit the scope of
relationships between medical practitioners and other parties. Under such laws,
business corporations such as UCI, UCI-SC and UCI-GA are prohibited from
practicing medicine or exercising control over the provision of medical
services. In order to comply with such laws, all medical services at our centers
are provided by or under the supervision of the P.A.'s pursuant to contracts
with UCI's wholly-owned subsidiaries. The P.A.'s are organized so that all
physician services are offered by the physicians who are employed by the P.A.'s.
None of UCI, UCI-SC or UCI-GA employs practicing physicians as practitioners,
exerts control over any physician's decisions regarding medical care or
represents to the public that it offers medical services.
As described above, UCI-SC has entered into an Administrative Services Agreement
with Doctor's Care, P.A. and UCI-GA has entered into a similar Administrative
Services Agreement with the P.A. operating in Tennessee pursuant to which UCI-SC
and UCI-GA, as applicable, perform all non-medical management of the applicable
P.A.'s and have exclusive authority over all aspects of the business of the
P.A.'s (other than those directly related to the provision of patient medical
services or as otherwise prohibited by state law). (See Item 1. Business -
Organizational Structure.)
Because of the unique structure of the relationships existing between UCI-SC,
UCI-GA and the P.A.'s, many aspects of our business operations have not been the
subject of state or federal regulatory interpretation. We have no assurance that
a review by the courts or regulatory authorities of the business formerly or
currently conducted by us will not result in a determination that could
adversely affect our operations or that the healthcare regulatory environment
will not change so as to restrict the existing operations or any potential
expansion of our business.
Third Party Reimbursements
Approximately seven percent of our revenues is derived from payments made by
government-sponsored health care programs (principally, Medicare and Medicaid).
As a result, any change in reimbursement regulations, policies, practices,
interpretations or statutes could adversely affect our operations. State and
federal civil and criminal statutes also impose substantial penalties, including
civil and criminal fines and imprisonment, on healthcare providers that
fraudulently or erroneously bill governmental or other third-party payors for
healthcare services. We believe we are in material compliance with such laws,
but we have no assurance that our activities will not be challenged or
scrutinized by governmental authorities.
Federal Anti-Kickback and Self-Referral Laws
Certain provisions of the Social Security Act, commonly referred to as the
"Anti-kickback Statute," prohibit the offer, payment, solicitation or receipt of
any form of remuneration in return for the referral of Medicare or state health
program patients or patient care opportunities, or in return for the
recommendation, arrangement, purchase, lease or order of items or services that
are covered by Medicare or state health programs. Although we believe that we
are not in violation of the Anti-kickback Statute or similar state statutes, our
operations do not fit within any of the existing or proposed federal safe
harbors.
The Office of the Inspector General (the "OIG"), the government office that is
charged with the enforcement of the federal Anti-kickback Statute, has issued an
advisory opinion regarding a proposed management services contract that involved
a cost plus a percentage of net revenue payment arrangement ("Advisory Opinion
98-4"). Based on its analysis of the intent and scope of the Anti-kickback
Statute, the OIG determined that it could not approve the arrangement because
the structure of the management agreement raised the following concerns under
the Anti-kickback Statute: (i) the agreement might include financial incentives
to increase patient referrals; (ii) the agreement did not include any controls
to prevent over utilization; and (iii) the percentage billing arrangement may
include financial incentives that increase the risk of abusive billing
practices. The OIG opinion did not find that the management arrangement violated
the Anti-kickback Statute, rather that the arrangement may involve prohibited
remuneration absent sufficient controls to minimize potential fraud and abuse.
An OIG advisory opinion is only legally binding on the Department of Health and
Human Services (including the OIG) and the requesting party and is limited to
the specific conduct of the requesting party because additional facts and
circumstances could be involved in each particular case. Accordingly, we believe
that Advisory Opinion 98-4 does not have broad application to our provision of
nonmedical management and administrative services for the centers. We also
believe that we and the centers have implemented appropriate controls to ensure
that the arrangements between us and the centers do not result in abusive
billing practices or the over utilization of items and services paid for by
Federal health programs.
The applicability of the Anti-kickback Statute to many business transactions in
the health care industry, including our service agreements with the centers and
our development of ancillary services, has not been subject to any significant
judicial and regulatory interpretation. We believe that although remuneration
for our management services is provided for under our service agreements with
the centers, we are not in a position to make or influence referrals of patients
or services reimbursed under Medicare or state health programs to the centers.
In addition, we are not a separate provider of Medicare or state health program
reimbursed services. Consequently, we do not believe that the service and
management fees payable to us should be viewed as remuneration for referring or
influencing referrals of patients or services covered by such programs as
prohibited by the Anti-kickback Statute.
Significant prohibitions against physician referrals were enacted by the U.S.
Congress in the Omnibus Budget Reconciliation Act of 1993. Subject to certain
exemptions, a physician or a member of his or her immediate family is prohibited
from referring Medicare or Medicaid patients to an entity providing "designated
health services" in which the physician has an ownership or investment interest
or with which the physician has entered into a compensation arrangement. While
we believe we are currently in compliance with such legislation, future
regulations could require us to modify the form of our relationships with
physician groups.
State Anti-Kickback and Self-Referral Laws
Some states have also enacted similar self-referral laws, and we believe that
more states will likely follow. We believe that our practices fit within
exemptions contained in such laws. Nevertheless, in the event we expand our
operations to certain additional jurisdictions, structural and organizational
modifications of our relationships with physician groups might be required to
comply with new or revised state statutes. Such modifications could adversely
affect our operations.
Through our wholly owned subsidiaries, UCI-SC and UCI-GA, we provide management
and administrative services to the centers in South Carolina and Tennessee.
South Carolina and Tennessee have adopted anti-kickback and self-referral laws
that regulate financial relationships between health care providers and entities
that provide health care services. The following is a summary of the applicable
state anti-kickback and self-referral laws.
South Carolina
South Carolina's Provider Self-Referral Act of 1993 generally provides that a
health care provider may not refer a patient for the provision of any designated
health service to an entity in which the health care provider is an investor or
has an investment interest. Under our current operations, we do not believe we
are entities providing designated health services for purposes of the South
Carolina Provider Self-Referral Act. The centers provide all health care
services to patients through employees of the P.A. No provider investors in the
P.A. refer patients to the centers for designated health care services.
Accordingly, under South Carolina law, we believe that the provider
self-referral prohibition would not apply to our centers or operations in South
Carolina.
In addition to self-referral prohibitions, South Carolina's Provider
Self-Referral Act of 1993 also prohibits the offer, payment, solicitation, or
receipt of a kickback, directly or indirectly, overtly or covertly, in cash or
in kind, for referring or soliciting patients. We believe that payment
arrangements are reasonable compensation for services rendered and do not
constitute payments for referrals.
Tennessee
The Tennessee physician conflict of interest/disclosure law provides that
physicians are free to enter into lawful contractual relationships, including
the acquisition of ownership interests in health facilities. The law further
recognizes that these relationships can create potential conflicts of interests,
which shall be addressed by the following: (a) the physician has a duty to
disclose to the patient or referring colleagues such physician's ownership
interest in the facility or therapy at the time of referral and prior to
utilization; (b) the physician shall not exploit the patient in any way, as by
inappropriate or unnecessary utilization; (c) the physician's activities shall
be in strict conformity with the law; (d) the patient shall have free choice
either to use the physician's proprietary facility or therapy or to seek the
needed medical services elsewhere; and (e) when a physician's commercial
interest conflicts so greatly with the patient's interest as to be incompatible,
the physician shall make alternative arrangements for the care of the patient.
Because we are not a provider of health services, we believe that Tennessee's
conflict of interest/disclosure law does not apply to our current operations.
Even if the Tennessee conflict of interest/disclosure law were to apply, our
internal quality assurance/utilization review programs will help identify any
inappropriate utilization by a center.
Tennessee also has a law regulating healthcare referrals. The general rule is
that a physician who has an investment interest in a healthcare entity shall not
refer patients to the entity unless a statutory exception exists. A healthcare
entity is defined as an entity that provides healthcare services. We believe
that we do not fit within the definition of a "healthcare entity" because we are
not a provider of healthcare services. The centers provide all health care
services to patients through employees of the P.A. No provider investors in the
P.A. refer patients for designated health care services except the sole
physician shareholder of the P.A. We believe that referrals by the sole
shareholder of the P.A. come within a statutory exception. Accordingly, under
Tennessee law, we believe that the provider self-referral prohibition would not
apply to our centers or operations in Tennessee.
Tennessee's anti-kickback provision prohibits a physician from making payments
in exchange for the referral of a patient. In addition, under Tennessee law a
physician may not split or divide fees with any person for referring a patient.
The Tennessee Attorney General has issued opinions that determined that the
fee-splitting prohibition applied to management services arrangements. The
Tennessee fee-splitting prohibition contains an exception for reasonable
compensation for goods or services. We believe that our payment arrangements
with the centers are reasonable compensation for services rendered and do not
constitute payments for referrals or a fee-splitting arrangement.
Antitrust Laws
Because each of the P.A.'s is a separate legal entity, each may be deemed a
competitor subject to a range of antitrust laws that prohibit anti-competitive
conduct, including price fixing, concerted refusals to deal and division of
market. We believe we are in compliance with such state and federal laws that
may affect our development of integrated healthcare delivery networks, but we
have no assurance that a review of our business by courts or regulatory
authorities will not result in a determination that could adversely affect our
operations.
Healthcare Reform
As a result of the continued escalation of healthcare costs and the inability of
many individuals to obtain health insurance, numerous proposals have been or may
be introduced in the U.S. Congress and in state legislatures relating to
healthcare reform. We have no assurance as to the ultimate content, timing or
effect of any healthcare reform legislation, nor can we estimate at this time
the impact of potential legislation, which may be material on us.
Regulation of Risk Arrangements and Provider Networks
Federal and state laws regulate insurance companies, health maintenance
organizations and other managed care organizations. Generally, these laws apply
to entities that accept financial risk. Certain of the risk arrangements entered
into by us could possibly be characterized by some states as the business of
insurance. We, however, believe that the acceptance of capitation payments by a
healthcare provider does not constitute the conduct of the business of
insurance. Many states also regulate the establishment and operation of networks
of healthcare providers. Generally, these laws do not apply to the hiring and
contracting of physicians by other healthcare providers. South Carolina and
Tennessee do not currently regulate the establishment or operation of networks
of healthcare providers except where such entities provide utilization review
services through private review agents. We have no assurance that regulators of
the states in which we may operate would not apply these laws to require
licensure of our operations as an insurer or provider network. We believe that
we are in compliance with these laws in the states in which we currently do
business, but we have no assurance that future interpretations of these laws by
the regulatory authorities in South Carolina, Tennessee or the states in which
we may expand in the future will not require licensure of our operations as an
insurer or provider network or a restructuring of some or all of our operations.
In the event we are required to become licensed under these laws, the licensure
process can be lengthy and time consuming and, unless the regulatory authority
permits us to continue to operate while the licensure process is progressing, we
could experience a material adverse change in our business while the licensure
process is pending. In addition, many of the licensing requirements mandate
strict financial and other requirements that we may not immediately be able to
meet. Further, once licensed, we would be subject to continuing oversight by and
reporting to the respective regulatory agency.
Employees
As of September 30, 2002, we had 520 employees (395 on a full-time equivalent
basis). This amount includes 110 medical providers employed by the P.A.'s.
Item 2. Properties
All but one of our primary care center's facilities are leased. The properties
are generally located on well-traveled major highways, with easy access. Each
property offers free, off-street parking immediately adjacent to the center. One
center is leased from an entity affiliated with one of our directors, and one of
the centers is leased from a physician employee of the P.A.'s.
Our centers are broadly distributed throughout the state of South Carolina, and
two are in Knoxville, Tennessee. Fifteen primary care centers are in the
Columbia, South Carolina region (including three physical therapy offices),
seven in the Charleston, South Carolina region (including one physical therapy
office), four in the Myrtle Beach, South Carolina region, one in the Aiken,
South Carolina region, seven in the Greenville-Spartanburg, South Carolina
region (including one physical therapy office) and two in the Knoxville,
Tennessee region (including one physical therapy office). Our corporate offices
are located on the second floor of one of the Columbia, South Carolina
locations. The centers are all in free-standing buildings in good repair.
Item 3. Legal Proceedings
We are a party to various claims, legal activities and complaints arising in the
normal course of business. In the opinion of management and legal counsel,
aggregate liabilities, if any, arising from legal actions would not have a
material adverse effect on our financial position.
On November 2, 2001, we filed a voluntary petition for reorganization under
Chapter 11 of the United States Bankruptcy Code (the "Bankruptcy Code") in the
United States Bankruptcy Court for the District of South Carolina (the
"Bankruptcy Court"). We remained in possession of our properties and assets, and
our management continued to operate our business as debtors-in-possession. As
debtors-in-possession, we were authorized to continue to operate our businesses,
but we were not allowed to engage in transactions outside the ordinary course of
business without the approval, after notice and an opportunity for a hearing, of
the Bankruptcy Court. Pursuant to the automatic stay provisions of the
Bankruptcy Code, all actions to collect pre-petition indebtedness of us, as well
as most other pending litigation against us, were stayed. In addition, as
debtors-in-possession, we had the right, subject to the approval of the
Bankruptcy Court and certain other conditions, to assume or reject any
pre-petition executory contracts or unexpired leases.
The Bankruptcy Court approved payment of certain pre-petition liabilities, such
as employee wages and benefits, and settlement of certain trade payable claims.
In addition, the Bankruptcy Court allowed for the retention of legal and
financial professionals to advise in the bankruptcy proceedings.
Each of our Plans of Reorganization, as amended, was confirmed by the Court by
August 8, 2002, and we have, therefore, emerged from the Chapter 11 protection
of the Court.
Item 4. Submission of Matters to a Vote of Security Holders
Not applicable.
PART II
Item 5. Market for Registrant's Common Equity and Related Stockholder Matters
Until October 19, 1998, UCI's common stock was traded on the NASDAQ SmallCap
Market under the symbol UCIA. On October 20, 1998, UCI's common stock was
delisted for trading on the NASDAQ SmallCap Market as a consequence of UCI's
failure to meet certain quantitative requirements under the NASD's expanded
listing criteria. Trading in UCI's common stock is currently conducted in the
over-the-counter market. The prices set forth below indicate the high and low
bid prices reported on the over-the-counter bulletin board. The quotations
reflect inter-dealer prices without retail markup, markdown or commission and
may not necessarily reflect actual transactions.
Bid Price
--------------------------
High Low
--------- ---------
Fiscal Year Ended September 30, 2002
1st quarter (10/01/01 - 12/31/01) $.30 $.15
2nd quarter (01/01/02 - 03/31/02) .23 .16
3rd quarter (04/01/02 - 06/30/02) .30 .19
4th quarter (07/01/02 - 09/30/02) .33 .26
Fiscal Year Ended September 30, 2001
1st quarter (10/01/00 - 12/31/00) $.41 $.31
2nd quarter (01/01/01 - 03/31/01) .39 .30
3rd quarter (04/01/01 - 06/30/01) .35 .28
4th quarter (07/01/01 - 09/30/01) .37 .26
As of December 16, 2002, there were 308 stockholders of record of UCI's common
stock, excluding individual participants in security position listings.
UCI has not paid cash dividends on its common stock since its inception and has
no plans to declare cash dividends in the foreseeable future.
Item 6. Selected Financial Data
STATEMENT OF OPERATIONS DATA
- ----------------------------------------------------------------------------------------------------------------------------
(In thousands, except per share data)
------------------------------------------------------------------------------
------------------------------------------------------------------------------
For the year ended September 30,
------------------------------------------------------------------------------
------------ -- ------------- -- ------------ -- ------------ -- -------------
2002 2001 2000 1999 1998
------------ ------------- ------------ ------------ -------------
Revenues $ 38,527 $ 38,117 $ 39,953 $ 40,470 $ 37,566
Net income (loss) 1,394 (1,475) (6,102) 910 (10,508)
Basic and diluted earnings (loss) per share
.14 (.15) (.63) .11 (1.61)
Basic weighted average number of
shares outstanding 9,651 9,651 9,651 8,537 6,545
Diluted weighted average number of
shares outstanding 9,651 9,651 9,651 8,544 6,545
BALANCE SHEET DATA
- ----------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------- ------------ -- ------------ -- ------------ -- ------------- -- -------------
(In thousands, except per share data)
------------------------------------------------------------------------------
------------------------------------------------------------------------------
At September 30,
------------------------------------------------------------------------------
------------ -- ------------ -- ------------ -- ------------- -- -------------
2002 2001 2000 1999 1998
------------ ------------ ------------ ------------- -------------
Working capital $ 2,515 $ (6,245) $ (6,230) $ (2,289) $ (3,718)
Property and equipment, net 3,765 3,977 4,326 4,797 5,475
Total assets 14,517 14,983 17,782 23,354 26,202
Long-term debt, including current portion
4,079 7,210 8,952 9,444 11,988
Stockholders' equity (deficiency) 190 (1,204) 271 6,373 987
See Note 1 to the accompanying financial statements, which discusses the impact
of accounting changes on the information reflected above in selected financial
data.
Item 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations
The following discussion and analysis provides information that we believe is
relevant to an assessment and understanding of our consolidated results of
operations and financial condition. This discussion should be read in
conjunction with the consolidated financial statements and notes thereto.
Critical Accounting Policies
We have adopted accounting policies, which we believe will result in an accurate
presentation of the financial statements. We consider critical accounting
policies to be those that require more significant judgments and estimates in
the preparation of our financial statements and include the following: (1)
revenue recognition; (2) allowance for doubtful accounts; (3) consideration of
impairment of intangible assets; and (4) valuation reserve on net deferred tax
assets.
Revenue recognition -
We record revenues at the estimated net amount that we expect to receive from
patients, employers, third party payors, and others at the time we perform the
services. We record contractual allowances when we prepare the related bills to
our customers. We bill some third parties at discounted and negotiated amounts.
Because we bill at the discounted amounts, we do not need to estimate third
party settlements.
Allowance for doubtful accounts -
We maintain our allowances for doubtful accounts for estimated losses, which
may result from the inability of our customers to make required payments.
Allowances are based on the likelihood of recoverability of accounts receivable
considering such factors as past experience and taking into account current
collection trends that are expected to continue. Factors taken into
consideration in estimating the reserves are amounts past due, in dispute, or a
client that we believe might be having financial difficulties. If economic,
industry, or specific customer business trends worsen beyond earlier estimates,
we increase the allowances for doubtful accounts by recording additional
expense.
Consideration of impairment of intangible assets -
We evaluate the recovery of the carrying amount of excess of cost over fair
value of assets acquired by determining if a permanent impairment has occurred.
This evaluation is done annually or more frequently if indicators of permanent
impairment arise. Indicators of a permanent impairment include, among other
things, significant adverse change in legal factors or the business climate, an
adverse action by a regulator, unanticipated competition, loss of key personnel
or allocation of goodwill to a portion of business that is to be sold or
otherwise disposed. As we allocate any excess of cost over fair value of assets
acquired on a center-by-center basis, we compare our centers fair value to our
carrying value for impairment issues. We perform our impairment test on
September 30th of each year. In addition to the annual impairment test, we are
required to perform an impairment test any time an indicator occurs, such as
those noted above. At such time as an impairment is determined, the intangible
assets are written off during that period. Although considerable care is taken
to ensure that impairment losses are recorded as soon as indicators of
impairment are noted, material differences could occur if different, but
nonetheless reasonably plausible, indicators existed.
Valuation reserve on net deferred tax assets -
We record a valuation allowance to reduce our deferred tax assets to the amount
that is more likely than not to be realized. As of June 30, 2002, we recorded a
valuation allowance that reduced our deferred tax assets to equal our deferred
tax liability.
Basis of Presentation
Our consolidated financial statements include the accounts of UCI, UCI-SC,
UCI-GA and the P.A.'s. Such consolidation is required under Emerging Issues Task
Force (EITF) 97-2 as a consequence of the nominee shareholder arrangement that
exists with respect to each of the P.A.'s. In each case, the nominee (and sole)
shareholder of the P.A. has entered into an agreement with UCI-SC or UCI-GA, as
applicable, that satisfies the requirements set forth in footnote 1 of EITF
97-2. Under the agreement, UCI-SC or UCI-GA, as applicable, in its sole
discretion, can effect a change in the nominee shareholder at any time for a
payment of $100 from the new nominee shareholder to the old nominee shareholder,
with no limits placed on the identity of any new nominee shareholder and no
adverse impact resulting to any of UCI-SC, UCI-GA or the P.A. resulting from
such change.
In addition to the nominee shareholder arrangements described above, each of
UCI-SC and UCI-GA have entered into Administrative Service Agreements with the
P.A.'s. (See Item 1. Business - "Organizational Structure" for a detailed
description of the Administrative Service Agreements.) As a consequence of the
nominee shareholder arrangements and the Administrative Service Agreements, we
have a long-term financial interest in the affiliated practices of the P.A.'s.
According to EITF 97-2, the application of FASB Statement No. 94 (Consolidation
of All Majority-Owned Subsidiaries), and FASB 141 (Business Combinations), UCI
must consolidate the results of the affiliated practices with those of UCI.
The P.A.'s enter into employment agreements with physicians for terms ranging
from one to five years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license. Over 79% of the physicians employed by the P.A.'s are paid on
an hourly basis for time scheduled and worked at the medical centers. The other
physicians are salaried. Approximately 25 of the physicians have incentive
compensation arrangements; however, no amounts were accrued or paid that were
significant during our three prior fiscal years. Any incentive compensation is
based upon a percentage of non-ancillary collectible charges for services
performed by a provider. Percentages range from 3% to 17% and vary by individual
employment contract. As of September 30, 2002 and 2001, the P.A.'s employed 110
and 109 medical providers, respectively.
The net assets of the P.A.'s are not material for any period presented, and
intercompany accounts and transactions have been eliminated.
We do not allocate all indirect costs incurred at the corporate offices to the
centers on a center-by-center basis. Therefore, all discussions below are
intended to be in the aggregate for us as a whole.
Chapter 11 Bankruptcy Filing
On November 2, 2001, we filed a voluntary petition for reorganization under
Chapter 11 of the United States Bankruptcy Code (the "Bankruptcy Code") in the
United States Bankruptcy Court for the District of South Carolina (the
"Bankruptcy Court"). We remained in possession of our properties and assets, and
our management continued to operate our business as debtors-in-possession. As
debtors-in-possession, we were authorized to continue to operate our businesses,
but we did not engage in transactions outside the ordinary course of business
without the approval, after notice and an opportunity for a hearing, of the
Bankruptcy Court. Pursuant to the automatic stay provisions of the Bankruptcy
Code, all actions to collect pre-petition indebtedness of us, as well as most
other pending litigation against us, were stayed. In addition, as
debtors-in-possession, we had the right, subject to the approval of the
Bankruptcy Court and certain other conditions, to assume or reject any
pre-petition executory contracts or unexpired leases.
The Bankruptcy Court approved payment of certain pre-petition liabilities, such
as employee wages and benefits, and settlement of certain trade payable claims.
In addition, the Bankruptcy Court allowed for the retention of legal and
financial professionals to advise in the bankruptcy proceedings.
By August 8, 2002, the Bankruptcy Court confirmed each of our Plans of
Reorganization.
Comparison of Results of Operations for Fiscal Years 2002, 2001, and 2000
Revenues of $38,527,000 in fiscal year 2002 reflected an increase of
approximately 1% from the fiscal year 2001 revenues of $38,117,000, which
reflected a decrease of 5% from the amount reported for fiscal year 2000. The
following reflects revenue trends from fiscal year 1998 through fiscal year
2002:
For the year ended September 30, (in thousands)
-------------------------------------------------------------------------------------------
-------------- -- ---------------- -- -------------- --- --------------- -- ---------------
2002 2001 2000 1999 1998
-------------- ---------------- -------------- --------------- ---------------
--------------
Revenues $ 38,527 $ 38,117 $ 39,953 $ 40,470 $ 37,566
Operating Costs 36,288 35,546 38,127 35,975 39,094
Operating Margin 2,238 2,572 1,827 4,495 (1,528)
The small increase in revenues from fiscal year 2001 to fiscal year 2002 is
attributed to an increase in laboratory services offered during the year and
some small increases in insurance payor fee schedules. The decrease in revenue
for fiscal year 2001 is attributed primarily to the shutdown of the Atlanta
centers (to be discussed later). Revenues for the Atlanta centers declined by
$1,059,000, from $2,648,000 for fiscal year 1999 to $1,589,000 for fiscal year
2000 and was zero ($0.00) in fiscal year 2001.
The number of our centers increased from 34 to 36 from September 30, 2000 to
September 30, 2001. The additions were two physical therapy offices (one in the
Greenville-Spartanburg region and one in the Charleston region). The number of
centers in operation remained constant throughout the 2002 fiscal year.
The number of our centers decreased from 40 to 34 from September 30, 1999 to
September 30, 2000. Of the six centers closed, five were in the Atlanta region
and the sixth was a physical therapy site in the Greenville-Spartanburg region,
which was opened for only a short period in the fourth quarter of fiscal year
1999 and the first quarter of fiscal year 2000.
During the past three fiscal years, we have continued our services provided to
members of HMOs. In these arrangements, we, through the P.A.'s, act as the
designated primary caregiver for members of HMOs who have selected one of our
centers or providers as their primary care provider. In fiscal year 1994, we
began participating in an HMO operated by Companion HealthCare Corporation
(CHC), a wholly owned subsidiary of Blue Cross Blue Shield of South Carolina
(BCBS). BCBS, through CHC, is a primary stockholder of UCI. Including its
arrangement with CHC, we now participate in four HMOs and are the primary care
gatekeeper for more than 10,000 lives in fiscal years 2002, 2001, and 2000. As
of September 30, 2002, all of these HMOs use a discounted fee-for-service basis
for payment. HMOs do not, at this time, have a significant penetration into the
South Carolina market; we are not certain if the market share of HMOs will grow
in the areas in which we operate clinics.
Sustained revenues in fiscal years 2002, 2001, and 2000 also reflect our
occupational medicine and industrial health services (these revenues are
referred to as employer paid and "workers compensation" on the table below).
Approximately 22% of our total revenue was derived from these occupational
medicine services in fiscal year 2002, 22% in fiscal year 2001 and 25% in fiscal
year 2000. We also entered into an agreement with Companion Property and
Casualty Insurance Company (CP&C) wherein we act as the primary care provider
for injured workers of firms insured through CP&C. CP&C is a primary stockholder
of UCI.
Patient encounters were 459,000 in fiscal year 2002, 472,000 in fiscal year 2001
and 504,000 in fiscal year 2000. The decrease in the number of patient visits
was mainly in the employer paid line of business and reflects a decrease in the
number of drug screens we performed. These procedures are low revenue ($15-$20
per encounter) and were not marketed as heavily in recent years.
No new significant competition entered our market during fiscal years 2002,
2001, and 2000.
The decrease in the operating margin in 2002 of approximately one percent was
largely the result of salary increases and increases in other medical expenses.
The improvement in the operating margin during fiscal year 2001 was due to the
elimination of the Atlanta operations during fiscal year 2000.
The operating margin decreased to $1,827,000 in fiscal year 2000 from $4,495,000
in fiscal year 1999 partially due to the poor performance of the Atlanta centers
for the first nine months of the fiscal year until their closure on June 30,
2000. For the nine months ending June 30, 2000, the Atlanta centers had an
operating deficit of approximately $1,143,000 as compared to an operating
deficit of approximately $730,000 for the twelve months of fiscal year 1999.
Approximately $400,000 of the decline in the operating deficit from fiscal year
1999 to fiscal year 2000 was attributable to the two Knoxville centers, one of
which moved to a new location in early fiscal year 2000. This move resulted in a
severe reduction of business for approximately six months, but began to improve
over the last quarter of fiscal year 2000. The remainder of the decrease was
primarily due to continuing costs pressures of managed care and due to an
increase of $519,000 in bad debt expense in fiscal year 2000 as compared to
fiscal year 1999, and a $379,000 change in estimate in fiscal year 1999 reducing
lease expense, as discussed in Note 14 to the financial statements.
The following table breaks out our revenue and patient visits by revenue source
for fiscal years 2002, 2001, and 2000.
Percent of Percent of
Patient Visits Revenue
--------------------- ------------------------
2002 2001 2000 2002 2001 2000
------- ------ ------ ------- ------ ---------
16 19 17 14 17 18
Patient Pay
11 12 14 6 7 8
Employer Paid
9 12 12 9 12 14
HMO
11 10 8 14 15 17
Workers Compensation
10 8 7 7 6 6
Medicare/Medicaid
40 35 36 46 38 30
Managed Care Insurance
3 4 6 4 5 7
Other (Commercial Indemnity, Champus, etc.)
As managed care plans attempt to cut costs, they typically increase the
administrative burden of providers like us by requiring referral approvals and
by requesting hard copies of medical records before they will pay claims. The
number of patients at our centers that are covered by a managed care plan versus
a traditional indemnity plan continues to grow. Management expects this trend to
continue.
Bad debt expense, a component of operating costs, was approximately $1,845,000
(or approximately 5% of revenue) for fiscal year 2002, $1,495,000 (or
approximately 4% of revenue) for fiscal year 2001 and $2,808,000 (or
approximately 7% of revenue) for fiscal year 2000. The expenses from bad debts
were higher in fiscal year 2000 due to the difficulties encountered in the
collection of amounts associated with patients seen at the centers acquired
during fiscal year 1998 (Atlanta centers) that were closed in fiscal year 2000.
The collection percentage for the established South Carolina centers has
remained constant at approximately 96% for the past 5 to 6 years.
We continually evaluate the operations of our physician practice centers and
assess the centers for impairment when certain indicators of impairment are
present. At September 30, 2002, no operating centers were considered to be
showing indications of impairment. At September 30, 2001, three centers were,
upon review, deemed to have impaired goodwill. One center in the Columbia region
and one center in the Greenville-Spartanburg region had decreased profitability
during fiscal year 2001 due to changes in the assigned physicians. The goodwill
for these two centers was considered impaired at September 30, 2001 and was,
therefore, written off. Additionally, as of September 30, 2001, a decision had
been made to combine the two Knoxville locations into one and, therefore, the
goodwill associated with the closed locations was deemed to be impaired and,
therefore, written off. In May 2000, we announced our intention to close our
Georgia physician practice centers effective June 30, 2000. The performance of
these centers, which were originally acquired in May 1998, did not meet our
expectations during fiscal year 2000, and we were no longer committed to the
Georgia market. We either sold the property and equipment at these centers for
an amount approximating the net book value of the fixed assets or transferred
the property and equipment to our other locations. The long-lived assets and
related goodwill for these centers was assessed for impairment under a held for
use model as of March 31, 2000. As a result of the decision to close these
centers, coupled with the fact that the remaining projected undiscounted cash
flows were less than the carrying value of the long-lived assets and goodwill
for these centers, we recorded an impairment in the quarter ended March 31, 2000
of approximately $3,567,000 to reduce the goodwill to its fair value. This
reduction is a component of the line item Realignment and Impairment Charges.
Additionally, we incurred additional costs associated with the decision to close
the Georgia centers during the third and fourth quarters of fiscal year 2000.
These costs relate primarily to exiting certain lease obligations. The estimated
lease obligations, net of estimated sub-lease income, were approximately
$242,000 at September 30, 2000. The total costs related to lease obligations and
employee contractual liabilities for the Atlanta centers closed June 30, 2000
was $561,000, which is the other component of the line item Realignment and
Impairment Charges.
During the second quarter of fiscal year 2000 and the fourth quarter of fiscal
year 2001, the above analysis resulted in an impairment charge of approximately
$3,567,000 and $753,000 to goodwill for centers that had been closed (i.e.,
Atlanta region) in fiscal year 2000 and for three underperforming centers in
fiscal year 2001. This charge is a component of the line item Realignment and
Impairment Charges.
Depreciation and amortization expense decreased to $1,022,000 in fiscal year
2002, down from $1,544,000 in fiscal year 2001 and $1,720,000 in fiscal year
2000. This decrease reflects lower amortization and depreciation resulting from
the closure of the Atlanta region and the adoption of SFAS No. 142, "Goodwill
and Other Intangible Assets" effective October 1, 2001 and the elimination of
the amortization of goodwill. Net interest expense increased to $2,236,000 in
fiscal year 2002 from $1,699,000 in fiscal year 2001. This increase was the
result of approximately $1,400,000 of interest and fees associated with the
settlement we made with various taxing authorities as part of our Chapter 11
reorganization. These amounts will be paid out over the next six years as per
the confirmed Plans of Reorganization. Without this change, interest expense of
approximately $836,000 would be a significant decrease from the prior year due
to lower interest rates and a smaller principal balance of debt from the prior
year. Net interest expense decreased to $1,699,000 in fiscal year 2001 from
$1,995,000 in fiscal year 2000 as a result of the overall decrease in long-term
debt due to principal pay downs and due to a continuing decline in interest
rates over the year.
We evaluate the valuation allowance regarding deferred tax assets on a more
likely than not basis. In determining that it was more likely than not that the
recorded deferred tax asset would be not realized, our management considered the
following:
o Recent historical operating results.
o Lack of sufficient liquidity to support operations.
o The budgets and forecasts that management and the Board of Directors have
adopted.
o The ability to utilize NOL's prior to their expiration.
o The potential limitation of NOL utilization in the event of a change in
ownership.
o The generation of future taxable income in excess of income reported on the
consolidated financial statements.
A valuation allowance of $6.6 and $7.1 million at September 30, 2002 and 2001,
respectively, remained necessary in the judgement of management because the
factors noted above did not support the utilization of less than a full
valuation allowance. The lack of consistent earnings, discussed above, was
considered in the decision to maintain a 100% valuation allowance of
approximately $6,600,000 at September 30, 2002, leaving no tax related asset
recorded.
Results of Operations for the Three Months Ended September 30, 2002 as Compared
to the Three Months Ended September 30, 2001:
The following summarizes the fiscal 2002 fourth quarter results of operations as
compared to the prior year:
For the Three Months Ended
(in 000's)
--------------------------------------------
---------------- -------- ------------------
09/30/2002 09/30/2001
---------------- ------------------
----------------
Revenues $ 9,724 $ 9,195
Operating Costs 9,618 9,272
Operating Margin 106 (77)
General and Administrative Expenses 31 12
Reorganization charges 215 --
Realignment and Impairment Charges -- 753
Depreciation and Amortization 246 389
Interest Expense, net 1,616 532
Gain extinguishment of debt (2,705) --
Net Income (loss) 703 (1,763)
Revenues of $9,724,000 for the quarter ending September 30, 2002 reflect an
increase of 6% from those of the fourth quarter of fiscal year 2001. The
increase is attributed to an increase in fee income associated with laboratory
services and some small increases in the fee schedule of some insurance payors
and an increase in physical therapy services provided.
Patient encounters remained constant at approximately 110,000 in the fourth
quarter of both fiscal years 2002 and fiscal year 2001.
The four percent increase in operating costs reflects routine salary adjustments
and increases in other medical costs.
The reduction in Depreciation and Amortization costs is due to our adoption of
SFAS No. 142, "Goodwill and Other Intangible Assets" effective October 1, 2001
and the elimination of the amortization of goodwill.
The increase in net interest expense was the result of approximately $1,400,000
of interest and fees associated with the settlement we made with various taxing
authorities as part of our Chapter 11 reorganization. These amounts will be paid
out over the next six years as part of the confirmed plans of reorganization.
Without this change, interest expense of approximately $216,000 for the quarter
would be a significant decrease from the previous year due to lower interest
rates and a smaller principal balance of debt.
During the 4th quarter of 2002, we recorded a gain on extinguishment of debt in
the amount of approximately $2,705,000 which resulted from a discharge of a
$1,500,000 of convertible subordinated debenture with accrued interest of
approximately $292,000; reducing the carrying value of compromised accounts
payable balances to their current present value by approximately $685,000; and
the termination of certain leases, with a recorded balance of approximately
$228,000, as provided for during the reorganization.
Financial Condition at September 30, 2002 and September 30, 2001
Cash and cash equivalents increased by $170,000 from September 30, 2001 to
September 30, 2002.
Accounts receivable increased from $6,297,000 at September 30, 2001 to
$6,350,000 at September 30, 2002. This increase was attributable to the increase
in revenues in the fourth quarter of fiscal year 2002.
The decreases in property and equipment are the result of regular depreciation.
Depreciation charges were somewhat offset on the Property and Equipment balance
by the net equipment purchases of approximately $809,000.
The reductions in long-term debt from September 30, 2001 to September 30, 2002
were the result of the regularly scheduled principal payments. Additionally,
approximately $800,000 of debt was transferred to accounts payable as part of
the Chapter 11 reorganization plan. Management believes that it will be able to
fund debt service requirements for the foreseeable future out of cash generated
through operations.
Liquidity and Capital Resources
We require capital principally to fund growth for working capital needs and for
the retirement of indebtedness. Our capital requirements and working capital
needs have been funded through a combination of external financing (including
bank debt and proceeds from the sale of common stock to CHC and CP&C), and
credit extended by suppliers.
As of September 30, 2002, we had no material commitments for capital
expenditures or for acquisition or start-ups.
Operating activities generated $2,377,000 of cash during fiscal year 2002,
compared to $2,716,000 during fiscal year 2001. Operations continued to generate
positive cash flow mainly due to an improvement in our overall operations, much
of which was the result of cost reductions that have remained in place
throughout 2002 and 2001, which shows up as the increase in operating margin on
the income statement. In addition, the extended payment terms realized through
the bankruptcy filing improved cash flow from operations.
Investing activities used $836,000 of cash during fiscal year 2002 and $727,000
used in fiscal year 2001 as a result of normal equipment upgrades in existing
centers.
We used approximately $1,372,000 of cash for financing activities in fiscal year
2002 to pay down the Line of Credit and a temporary year-end bank overdraft. We
used approximately $2,193,000 of cash during fiscal year 2001 to reduce debt. We
have no assurance that any additional financing, if required, will be available
on terms acceptable to us.
Overall, our current assets exceed our current liabilities at September 30,
2002.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to changes in interest rates primarily as a result of our
borrowing activities, which includes credit facilities with financial
institutions used to maintain liquidity and fund our business operations, as
well as notes payable to various third parties in connection with certain
acquisitions of property and equipment. The nature and amount of our debt may
vary as a result of future business requirements, market conditions and other
factors. The definitive extent of our interest rate risk is not quantifiable or
predictable because of the variability of future interest rates and business
financing requirements. We do not currently use derivative instruments to adjust
our interest rate risk profile.
Approximately $2,200,000 of our debt at September 30, 2002 was subject to fixed
interest rates and principal payments. Approximately $1,882,000 of our debt at
September 30, 2002 was subject to variable interest rates. Based on the
outstanding amounts of variable rate debt at September 30, 2002, our interest
expense on an annualized basis would increase approximately $18,000 for each
increase of one percent in the prime rate.
We do not utilize financial instruments for trading or other speculative
purposes, nor do we utilize leveraged financial instruments.
Item 8. Financial Statements and Supplementary Data
Reference is made to the Index to Financial Statements on Page 30.
Item 9. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure
Not applicable.
PART III
Item 10. Directors and Executive Officers of the Registrant
Directors
M.F. McFarland, III, M.D., 55, served as Chairman of the Board, President and
Chief Executive Officer of UCI from January 1987 through October 31, 2002 and as
a director of UCI since September 1984. From September 1984 until January 1987,
he served as Vice President of UCI. He served as Associate Professional Director
of the Emergency Department of Richland Memorial Hospital in Columbia, South
Carolina from 1978 to 1981 and was President of the South Carolina Chapter of
the American College of Emergency Physicians in 1979. Dr. McFarland is currently
a member of the Columbia Medical Society, the South Carolina Medical Association
and the American Medical Association. Dr. McFarland was most recently reelected
as a director at the annual meeting of stockholders in 1997.
Charles M. Potok, 54, has served as a director of UCI since September 1995 and
as Executive Vice President and Chief Operating Officer of Companion Property
and Casualty Company ("CP&C"), a wholly-owned subsidiary of BCBS, since March
1984. Mr. Potok is an Associate of the Casualty Actuarial Society and a member
of the American Academy of Actuaries. Prior to joining CP&C, Mr. Potok served as
Chief Property and Casualty Actuary and Director of the Property and Casualty
Division of the South Carolina Department of Insurance. Mr. Potok was most
recently reelected as a director at the annual meeting of stockholders in 1997.
A. Wayne Johnson, 52, has served as Chairman and Chief Executive Officer of
MainStreet Healthcare Corporation ("MHC") from its inception in February 1996.
In addition to Mr. Johnson's MainStreet responsibilities, effective December 8,
1999, he assumed the role of Executive Vice President of Providan Financial, a
San Francisco-based financial services company. Mr. Johnson has 24 years of
entrepreneurial and business operations experience in the field of financial
services and corporate development. Prior to co-founding MHC in February 1996,
Mr. Johnson had served since 1991 as President of one of the major operating
subsidiaries of First Data Corporation and Chief Marketing Officer and strategic
planner for First Data Card Services Group, a subsidiary of First Data
Corporation. Mr. Johnson was the founder of both Integratec, a collection
company, and QualiServ, a credit card outsourcing service company. Mr. Johnson
was initially elected as a director at the annual meeting of stockholders in
1999.
Ashby M. Jordan, M.D., 64, has served as a director of UCI since August 1996 and
as Vice President of Medical Affairs of BCBS since December 1986. Prior to
joining BCBS, Dr. Jordan was the Vice President of Medical Affairs for CIGNA
HealthPlan of South Florida, Inc. Dr. Jordan is Board Certified by the American
Board of Pediatrics. Dr. Jordan was most recently reelected as a director at the
annual meeting of stockholders in 1999.
John M. Little, Jr., M.D., MBA, 53, has served as a director of UCI since August
11, 1998 and as Chief Medical Officer of Companion HealthCare Corporation
("CHC"), a wholly-owned subsidiary of BCBS, since 1996. Additionally, he has
served since 1994 as Medical Director of Managed Care Services of CHC, as
Chairman of the Quality Assurance Committee and the Pharmacy and Therapeutics
Committee of CHC and as a Co-Chair of the Managed Care Oversight Committee of
CHC. Prior to joining CHC in 1994, Dr. Little served as Assistant Chairman for
Academic Affairs, Department of Family Practice, Carolinas Medical Center,
Charlotte, North Carolina from 1992 to 1994. Dr. Little was most recently
reelected as a director at the annual meeting of stockholders in 1999.
Harold H. Adams, Jr., 56, has served as a director of UCI since June 1994 and as
President and owner of Adams and Associates, International, Adams and
Associates, and Southern Insurance Managers since June 1992. He served as
President of Adams Eaddy and Associates, an independent insurance agency, from
1980 to 1992. Mr. Adams has been awarded the Chartered Property Casualty
Underwriter designation and is currently a member of the President's Board of
Visitors of Charleston Southern University in Charleston, South Carolina. He has
received numerous professional awards as the result of over 26 years of
involvement in the insurance industry and is a member of many professional and
civic organizations. Mr. Adams was most recently reelected as a director at the
annual meeting of stockholders in 2000.
Executive Officers
The following sets forth certain information concerning the persons who
currently serve as executive officers of UCI who do not also serve on the Board
of Directors.
D. Michael Stout, M.D., 57, has served as Executive Vice President of Medical
Affairs of UCI and DC-SC since 1985 and as President and Chief Executive Officer
of UCI, UCI-SC, UCI-GA and the P.A.'s since November 1, 2002. He is Board
Certified in Emergency Medicine and has been a member of the American College of
Emergency Physicians, the Columbia Medical Society and the American College of
Physician Executives.
Jerry F. Wells, Jr., 40, has served as Chief Financial Officer and Executive
Vice President of UCI since he joined UCI in February 1995 and as Corporate
Secretary of UCI since December 1996. He has served as Executive Vice President
of Finance, Chief Financial Officer and Corporate Secretary of UCI-SC since
December 1996, and of UCI-GA since its organization in February 1998, and as
Corporate Secretary of DC-SC since December 1996. Prior to joining the Company,
he served as a Senior Manager and consultant for PricewaterhouseCoopers LLP from
1985 until February 1995. Mr. Wells is a certified public accountant and is a
member of the American Institute of Certified Public Accountants, the South
Carolina Association of Certified Public Accountants and the North Carolina CPA
Association.
Board of Directors and Board Committees
Board of Directors
The Board of Directors met or acted by written consent a total of three times
during UCI's fiscal year ended September 30, 2002. No director attended fewer
than 75 percent of the total of such Board meetings and the meetings of the
committees upon which the director served. Among the standing committees
established by the Board of Directors are a Compensation Committee, an Audit
Committee, and a Revenue Enhancement Committee. The Board of Directors has not
established a nominating committee for recommending to stockholders candidates
for positions on the Board of Directors. Such functions are currently performed
by the Board of Directors acting as a whole. Currently, six directors serve on
the Board of Directors.
Audit Committee
The Audit Committee consists of Mr. Adams and Dr. Jordan. This committee
recommends to the Board of Directors the engagement of the independent auditors
for UCI, determines the scope of the auditing of the books and accounts of UCI,
reviews the reports submitted by the auditors, examines procedures employed in
connection with UCI's internal control structure, reviews and approves the terms
of acquisitions between UCI and any related party entities, undertakes certain
other activities related to the fiscal affairs of UCI and makes recommendations
to the Board of Directors as may be appropriate. This committee met one time
during UCI's fiscal year ended September 30, 2002.
Compensation Committee
The Compensation Committee consists of Dr. Little, Mr. Johnson, and Mr.
Potok. This committee monitors UCI's executive compensation plan, practice and
policies, including all salaries, bonus awards and fringe benefits, and makes
recommendations to the Board of Directors with respect to changes in existing
executive compensation plans and the formation and adoption of new executive
compensation plans. This committee met one time during UCI's fiscal year ended
September 30, 2002.
Revenue Enhancement Committee
The Revenue Enhancement Committee consists of Messrs. Adams and Potok. This
committee monitors UCI's ancillary and complementary services, and makes
recommendations to the Board of Directors with respect to changes in such
existing services. This committee did not meet during UCI's fiscal year ended
September 30, 2002.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the 1934 Act requires the directors and officers of UCI to file
reports of holdings and acquisitions in common stock with the Securities and
Exchange Commission. Based on our records and other information, UCI believes
that all SEC filing requirements applicable to its directors and officers were
complied with in respect to UCI's fiscal year ended September 30, 2002.
Item 11. Executive Compensation
The following table sets forth the total compensation earned during the fiscal
year ended September 30, 2002 and during each of the two prior fiscal years by
the President and Chief Executive Officer of UCI and the executive officers of
UCI whose annual compensation from UCI exceeded $100,000 for all services
provided to UCI. No other executive officer of the Company earned compensation
in excess of $100,000 for services provided to the Company in any of the three
fiscal years reflected in the table.
Long Term
Compensation
Annual Compensation Awards
Securities
Underlying All Other
Name and Principal Position Fiscal Year Salary (1) Bonus (1) Options Compensation (2)
--------------------------- ----------- ---------- --------- ------- ----------------
M. F. McFarland, III, M.D. 2002 $ 325,000 (3) $155,500 -- 9,272
Chairman, President and 2001 325,000 (3) -- -- 9,272
Chief Executive Officer 2000 325,000 (3) -- -- 9,272
D. Michael Stout, M.D. 2002 $ 210,000 (4$ 58,000 -- --
Executive Vice President of 2001 210,000 (4) -- -- --
Medical Affairs 2000 210,000 (4) -- -- --
Jerry F. Wells, Jr. 2002 $ 137,600 $ 38,000 -- --
Executive Vice President of 2001 112,000 -- -- --
Finance, Chief Financial Officer 2000 99,640 -- -- --
(1) Amounts included under the heading "Salary" and "Bonus" include
compensation from both UCI-SC and DC-SC. The remuneration described in
the table above does not include the cost to UCI of benefits furnished
to certain officers that were extended in connection with the conduct
of UCI's business. The amount of such benefits accrued for each of the
named executives in each of the years reflected in the table did not
exceed 10% of the total annual salary and bonus reported for such
executive in such year.
(2) Amounts included under the heading "All Other Compensation" are
comprised of premiums for long-term disability and life insurance
provided by UCI for the benefit of Dr. McFarland.
(3) For services performed by Dr. McFarland for UCI-SC, a wholly-owned
subsidiary of UCI, Dr. McFarland received an annual salary of $157,500
during each of the three fiscal years ended September 30, 2002. For
services performed by Dr. McFarland for DC-SC, an affiliated
professional association wholly owned by Dr. McFarland that contracts
with UCI-SC to provide all medical services at UCI's medical
facilities, Dr. McFarland received an annual salary of $167,500 for
each of the three fiscal years ended September 30, 2002.
(4) For services performed by Dr. Stout for UCI-SC, Dr. Stout received an
annual salary of $50,000 in each of the three fiscal years ended
September 30, 2002. For services performed by Dr. Stout for DC-SC, Dr.
Stout received an annual salary of $160,000 in each of the three fiscal
years ended September 30, 2002.
Fiscal Year-End Option Values
The following table sets forth certain information with respect to unexercised
options to purchase UCI's common stock held at September 30, 2002. None of the
named executive officers exercised any options during the fiscal year ended
September 30, 2002. Additionally, no options were granted to any officer or
director during the fiscal year ended September 30, 2002.
2002 FISCAL YEAR-END
OPTION VALUES
Number of Securities Underlying Value of Unexercised
Unexercised Options at In-the-Money
Fiscal Year End Options at Fiscal Year End
------------------------------------------ ---------------------------------------
Name Exercisable Unexercisable Exercisable Unexercisable
- ---------------------------------------------------- ---------------------- -------------------- -------------------
-- -- -- --
M.F. McFarland, III, M.D. Chairman, President and Chief Executive Officer
74,825 -- -- --
D. Michael Stout, M.D.
Executive Vice President of
Medical Affairs
134,825 -- -- --
Jerry F. Wells, Jr.
Executive Vice President of
Finance, Chief
Financial Officer
Director Compensation
Non-employee directors of UCI are paid a fee of $500 for attendance at each
meeting of UCI's Board of Directors. Non-employee directors of UCI are
reimbursed by UCI for all out-of-pocket expenses reasonably incurred by them in
the discharge of their duties as directors, including out-of-pocket expenses
incurred in attending meetings of the Board of Directors.
During the fiscal year ended September 30, 1996, UCI adopted a Non-Employee
Director Stock Option Plan (the "1996 Non-Employee Plan"). The 1996 Non-Employee
Plan provided for the granting of options to two non-employee directors for the
purchase of 10,000 shares of UCI's common stock at the fair market value as of
the date of grant. Under this plan, 5,000 options were issued to Harold H.
Adams, Jr. and 5,000 options were issued to Russell J. Froneberger. These
options are exercisable during the period commencing on March 20, 1999 and
ending on March 20, 2006. At September 30, 2002, there were stock options
outstanding under the 1996 Non-Employee Plan for 10,000 shares, all of which
were exercisable.
During the fiscal year ended September 30, 1997, UCI adopted a Non-Employee
Director Stock Option Plan (the "1997 Non-Employee Plan"). The 1997 Non-Employee
Plan provided for the granting of options to four non-employee directors for the
purchase of 20,000 shares of Common Stock at the fair market value as of the
date of grant. Under this plan, 5,000 options were issued each to Thomas G.
Faulds, Ashby M. Jordan, M.D., and Charles M. Potok. These options are
exercisable during the period commencing on March 28, 2000 and ending on March
28, 2007. At September 30, 2002, there were stock options outstanding under the
1997 Non-Employee Plan for 15,000 shares, all of which were exercisable.
Employment Contracts
None
Compensation Committee Interlocks and Insider Participation
During the fiscal year ended September 30, 2002, matters of executive
compensation were decided by the Compensation Committee of the Board of
Directors. The Compensation Committee is currently composed of Dr. Little, Mr.
Johnson and Mr. Potok.
Compensation Committee Report on Executive Compensation
The compensation of UCI's executive officers is generally determined by the
Compensation Committee of the Board of Directors. The following report with
respect to certain compensation paid or awarded to UCI's executive officers
during the fiscal year ended September 30, 2002 is furnished by the directors
who comprise the Compensation Committee.
General Policies. UCI's compensation program is intended to enable UCI to
attract, motivate, reward and retain the management talent to achieve corporate
objectives, and thereby increase shareholder value. UCI's policy is to provide
incentives to senior management to achieve both short-term and long-term
objectives. To attain these objectives, UCI's executive compensation program is
composed of a base salary and bonus.
Base Salary. Base salaries for each of Dr. McFarland, Dr. Stout and Mr. Wells
were determined by a subjective assessment of the executive officer's
performance, in light of the officer's responsibilities and position with UCI
and UCI's performance during prior periods. In evaluating overall UCI
performance, the primary focus is upon not only UCI's financial performance, but
also on the personal performance of the executives in areas such as quality
assurance and personal development.
Incentive Compensation. Incentive compensation for each of Dr. McFarland and Dr.
Stout was established in his respective employment agreement, both of which are
no longer in effect as of the date of this report, and is most influenced by
UCI's profitability. It is completely "at risk" depending upon UCI's
performance. Incentive compensation is reviewed periodically and from time to
time by the Compensation Committee and adjusted accordingly.
Chief Executive Officer Compensation. Dr. McFarland was one of the original
founders of UCI and devoted his career to UCI since its inception in 1984. Dr.
McFarland's overall compensation for the fiscal year ended September 30, 2002
consisted of his base salary and incentive compensation. In determining Dr.
McFarland's compensation, the Compensation Committee evaluated Dr. McFarland's
personal performance, the performance of UCI and Dr. McFarland's long-term
commitment to the success of and ownership position in UCI.
Stock Options. Executive compensation includes the grant of stock options in
order to more closely align the interests of the executive with the long-term
interests of the shareholders.
Report of Compensation Committee: John M. Little, Jr., MD, MBA; A. Wayne
Johnson; and Charles M. Potok
Performance Graph
The following graph compares cumulative total shareholder return of UCI's common
stock over a five-year period with The Nasdaq Stock Market (US) Index and with a
Peer Group of companies for the same period. Total shareholder return represents
stock price changes and assumes the reinvestment of dividends. The graph assumes
the investment of $100 on September 30, 1997.
(INSERT GRAPH HERE)
Fiscal Year Ended
-----------------------------------------------------------------------------------
09/30/97 09/30/98 09/30/99 09/30/00 09/30/01 09/30/02
----------- ---------- ----------- ---------- ---------- ----------
UCI Medical Affiliates, Inc. 100.00 45.00 22.50 16.25 12.40 10.40
Nasdaq Market Index 100.00 103.92 168.12 229.98 94.23 75.81
Peer Group 100.00 93.24 36.76 45.57 103.61 69.79
The members of the Peer Group are AmeriPath, Inc., Continucare Corporation,
IntegraMed America, Inc., Pediatrix Medical Group, Inc., and Metropolitan Health
Networks. Metropolitan Health Networks replaced PhyCor, Inc., which was a member
of the Peer Group for the 10-K for fiscal year ended September 30, 2001, because
based on our knowledge, PhyCor, Inc. has been liquidated in bankruptcy. The
returns of each company in the Peer Group have been weighted according to their
respective stock market capitalization for purposes of arriving at a Peer Group
average. The prices of UCI's common stock used in computing the returns
reflected above are the average of the high and low bid prices reported for
UCI's common stock during the fiscal quarter ended on such dates.
Item 12. Security Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
The following table sets forth certain information known to UCI regarding the
beneficial ownership of common stock as of December 16, 2002. Information is
presented for (i) stockholders owning more than five percent of the outstanding
common stock, (ii) each director and executive officer of UCI, individually, and
(iii) all directors and executive officers of UCI, as a group. The percentages
are calculated based on 9,650,515 shares of common stock outstanding on December
16, 2002.
Shares
Beneficially
Name Owned (1) Percentage
- ------------------------------------------------------------------------- --- ---------------- ------------
Main Street Healthcare Corporation (2).........................................2,901,396 30.10
Blue Cross Blue Shield of South Carolina (3)...................................2,624,623 27.20
M.F. McFarland, III, M.D. (4)....................................................728,519 7.55
Harold H. Adams, Jr................................................................2,500 --
Thomas G. Faulds......................................................................-- --
A. Wayne Johnson (5)...........................................................2,901,396 30.10
Ashby M. Jordan, M. D................................................................ -- --
John M, Little, Jr., M.D..............................................................-- --
Charles M. Potok......................................................................-- --
D. Michael Stout, M.D. (6).......................................................357,185 3.70
Jerry F. Wells, Jr. (7)..........................................................134,825 1.40
All current directors and executive officers
As a group (9 persons).....................................................4,124,425 42.74
* Amount represents less than 1.0 percent.
(1) Beneficial ownership reflected in the table is determined in accordance
with the rules and regulations of the SEC and generally includes voting
or investment power with respect to securities. Shares of common stock
issuable upon the exercise of options currently exercisable or
convertible, or exercisable or convertible within 60 days, are deemed
outstanding for computing the percentage ownership of the person
holding such options, but are not deemed outstanding for computing the
percentage ownership of any other person. Except as otherwise
specified, each of the stockholders named in the table has indicated to
us that such stockholder has sole voting and investment power with
respect to all shares of common stock beneficially owned by that
stockholder.
(2) The business address of the named beneficial owner is 2370 Main Street,
Tucker, Georgia 30084.
(3) The business address of the named beneficial owner is I-20 at Alpine
Road, Columbia, SC 29219. The shares reflected in the table are held of
record by CHC (2,006,442 shares) and CP&C (618,181 shares), each of
which is a wholly-owned subsidiary of BCBS.
(4) The business address of the named beneficial owner is 1829 Senate
Street, Columbia, SC 29201. Shares reflected in the table include
206,675 shares issuable pursuant to currently exercisable stock
options.
(5)......All shares reflected as beneficially owned are held of record by
MainStreet Healthcare Corporation. Mr. Johnson is Chairman, Chief
Executive Officer and a principal shareholder of MainStreet Healthcare
Corporation.
(6) Includes 74,825 shares issuable pursuant to currently exercisable stock
options. (7) All shares are issuable pursuant to currently exercisable stock
options.
Equity Compensation Plan Information
The following table gives information about our common stock that may be issued
upon the exercise of options, warrants and rights under all of our existing
equity compensation plans as of September 30, 2002.
Number of securities
remaining available for
Number of securities future issuance under
to be issued upon Weighted-average equity compensation
exercise of exercise price of plans {excluding
outstanding options, outstanding options, securities reflected in
Plan category warrants and rights warrants and rights column (a)}
- ---------------------------------- ----------------------- ----------------------- -------------------------
- ---------------------------------- ----------------------- ----------------------- -------------------------
(a) (b) (c)
Equity compensation plans
approved by security holders 524,950 2.49 409,350
Equity compensation plans not
approved by security holders
-- -- --
----------------------- ----------------------- -------------------------
----------------------- ----------------------- -------------------------
Total 524,950 2.49 409,350
======================= ======================= =========================
Item 13. Certain Relationships and Related Transactions
Administrative Services Agreements
UCI-SC has entered into an Administrative Services Agreement with DC-SC. UCI-GA
has entered into Administrative Services Agreements with Doctor's Care of
Tennessee, P.C. Under these Administrative Services Agreements, UCI-SC and
UCI-GA perform all non-medical management of the P.A.'s and have exclusive
authority over all aspects of the business of the P.A.'s (other than those
directly related to the provision of patient medical services or as otherwise
prohibited by state law). The non-medical management provided by UCI-SC and
UCI-GA includes, among other functions, treasury and capital planning, financial
reporting and accounting, pricing decisions, patient acceptance policies,
setting office hours, contracting with third party payors and all administrative
services. UCI-SC and UCI-GA provide all of the resources (systems, procedures
and staffing) to bill third party payors or patients, and provide all of the
resources (systems, procedures and staffing) for cash collection and management
of accounts receivables, including custody of the lockbox where cash receipts
are deposited. From the cash receipts, UCI-SC and UCI-GA pay all physician
salaries, operating costs of the centers and operating costs of UCI-SC and
UCI-GA. Compensation guidelines for the licensed medical professionals at the
P.A.'s are set by UCI-SC and UCI-GA, and UCI-SC and UCI-GA establish guidelines
for establishing, selecting, hiring and firing the licensed medical
professionals. UCI-SC and UCI-GA also negotiate and execute substantially all of
the provider contracts with third party payors, with the P.A.'s executing
certain of the contracts at the request of a minority of payors. Neither UCI-SC
nor UCI-GA loans or otherwise advances funds to any P.A. for any purposes.
During UCI's fiscal years ended September 30, 2002 and 2001, the P.A.'s received
an aggregate of approximately $38,527,000 and $38,117,000, respectively, in fees
prior to deduction by the P.A.'s of their payroll and other related deductible
costs covered under the Administrative Agreement and its predecessor agreement.
For accounting purposes, the operations of the P.A.'s are combined with the
operations of UCI and are reflected in our consolidated financial statements.
Pursuant to the employment agreement, in effect during the period covered by
this report, between DC-SC and Dr. McFarland, Dr. McFarland served as Executive
Medical Director of the centers and was paid an annual salary for his services
in such position. Pursuant to the employment agreement in effect during the
period covered by this report between DC-SC and Dr. Stout, Dr. Stout provided
medical services to DC-SC and was paid an annual salary for such services.
During the period covered by this report, Dr. McFarland was the Chief Executive
Officer of UCI and was the President, sole director and sole owner of DC-SC. As
of November 1, 2002, Dr. Stout has served as the President and Chief Executive
Officer of UCI, UCI-SC, UCI-GA, and the P.A.'s. During the period covered by
this report, Dr. Stout was the Executive Vice President of Medical Affairs for
UCI, UCI-SC and UCI-GA, and was the President, sole director and sole
stockholder of the P.A.'s.
Medical Center Leases
The Doctor's Care Northeast facility is leased from a partnership in which Dr.
McFarland is a general partner. The lease was renewed in October 1997 for a
fifteen-year term. The terms of this lease are believed to be no more or less
favorable to UCI-SC than those that would have been obtainable through
arm's-length negotiations with unrelated third parties for similar arrangements.
Total lease payments made by UCI-SC under this lease during the fiscal years
ended September 30, 2002 and 2001 were $96,000 each year, plus utilities and
real estate taxes.
Other Transactions with Related Parties
At October 31, 2002, CHC owned 2,006,442 shares of common stock and CP&C owned
618,181 shares of common stock, which combine to approximately 27.2 percent of
the outstanding common stock. Each of CHC and CP&C is a wholly-owned subsidiary
of BCBS. The following is a historical summary of purchases of common stock by
BCBS subsidiaries directly from UCI.
Price Total
Date BCBS Number per Purchase
Purchased Subsidiary of Shares Share Price
------------------- ----------------- ---------------- ---------------- ------------------
12/10/93 CHC 333,333 $1.50 $ 500,000
06/08/94 CHC 333,333 3.00 1,000,000
01/16/95 CHC 470,588 2.13 1,000,000
05/24/95 CHC 117,647 2.13 250,000
11/03/95 CHC 218,180 2.75 599,995
12/15/95 CHC 218,180 2.75 599,995
03/01/96 CHC 109,091 2.75 300,000
06/04/96 CP&C 218,181 2.75 599,998
06/23/97 CP&C 400,000 1.50 600,000
The common stock acquired by CHC and CP&C directly from UCI was purchased
pursuant to exemptions from the registration requirements of federal securities
laws available under Section 4(2) of the 1933 Act. Consequently, the ability of
the holders to resell such shares in the public market is subject to certain
limitations and conditions. The shares acquired by CHC and CP&C were purchased
at share prices below market value at the respective dates of purchase in part
as a consequence of the lower issuance costs incurred by us in the sale of these
unregistered securities and in part as consequence of the restricted nature of
the shares. CHC and CP&C have the right to require registration of the stock
under certain circumstances as described in the respective stock purchase
agreements. BCBS and its subsidiaries have the option to purchase as many shares
as may be necessary for BCBS and its subsidiaries to obtain ownership of 47
percent of the outstanding common stock in the event that UCI issues additional
stock to other parties (excluding shares issued to employees or directors of
UCI).
During the fiscal year ended September 30, 1998, UCI-SC entered into a capital
lease purchase agreement with BCBS for a new billing and accounts receivable
system, which includes computer equipment, for an aggregate purchase price of
$1,253,000. UCI-SC has the option to purchase the equipment at the end of the
lease term for $1. The lease obligation recorded at September 30, 2002 is
$628,000, which includes lease addenda. The terms of the lease purchase
agreement are believed to be no more or less favorable to UCI-SC than the terms
that would have been obtainable through arm's-length negotiations with unrelated
third parties for a similar billing and accounts receivable system, which
includes computer equipment.
During the fiscal year ended September 30, 1994, UCI-SC entered into an
agreement with CP&C pursuant to which UCI-SC, through DC-SC, acts as the primary
care provider for injured workers of firms carrying worker's compensation
insurance through CP&C. Additionally, during the fiscal year ended September 30,
1995, UCI-SC executed a $400,000 note payable to CP&C payable in monthly
installments of $4,546 (including 11 percent interest) from April 1, 1995 to
March 1, 2010. The terms of the agreement with CP&C are believed to be no more
or less favorable to UCI-SC than those that would have been obtainable through
arm's-length negotiations with unrelated third parties for similar arrangements.
UCI-SC, through DC-SC, provides services to members of a health maintenance
organization operated by CHC who have selected DC-SC as their primary care
provider. The terms of the agreement with CHC are believed to be no more or less
favorable to UCI-SC than those that would have been obtainable through
arm's-length negotiations with unrelated third parties for similar arrangements.
Item 14. Controls and Procedures
Annual evaluation of our Disclosure Controls and Internal Controls. Within the
90 days prior to the date of this Annual Report on Form 10-Q, we evaluated the
effectiveness of the design and operation of our "disclosure controls and
procedures" (Disclosure Controls), and our "internal controls and procedures for
financial reporting" (Internal Controls). This evaluation (the "Controls
Evaluation") was done under the supervision and with the participation of
management, including our Chief Executive Officer ("CEO") and Chief Financial
Officer ("CFO"). Rules adopted by the SEC require that in this section of the
Annual Report we present the conclusions of the CEO and the CFO about the
effectiveness of our Disclosure Controls and Internal Controls based on and as
of the date of the Controls Evaluation.
CEO and CFO Certifications. Appearing immediately following the Signatures
section of this Annual Report there is a form of Certification. The form of
Certification is required in accordance with Section 302 of the Sarbanes-Oxley
Act of 2002 (the "Section 302 Certification"). This section of the Annual Report
that you are currently reading is the information concerning the Controls
Evaluation referred to in the Section 302 Certifications, and this information
should be read in conjunction with the Section 302 Certifications for a more
complete understanding of the topics presented.
Disclosure Controls and Internal Controls. Disclosure Controls are procedures
that are designed with the objective of ensuring that information required to be
disclosed in our reports filed under the Securities Exchange Act of 1934 (the
"Exchange Act"), such as this Annual Report, is recorded, processed, summarized
and reported within the time periods specified in the SEC's rules and forms.
Disclosure Controls are also designed with the objective of ensuring that such
information is accumulated and communicated to our management, including the CEO
and CFO, as appropriate to allow timely decisions regarding required disclosure.
Internal Controls are procedures that are designed with the objective of
providing reasonable assurance that (1) our transactions are properly
authorized; (2) our assets are safeguarded against unauthorized or improper use;
and (3) our transactions are properly recorded and reported, all to permit the
preparation of our financial statements in conformity with generally accepted
accounting principles.
Limitations on the Effectiveness of Controls. Our management, including the CEO
and CFO, does not expect that our Disclosure Controls or our Internal Controls
will prevent all error and all fraud. A control system, no matter how well
conceived and operated, can provide only reasonable, not absolute, assurance
that the objectives of the control system are met. Further, the design of a
control system must reflect the fact that there are resource constraints, and
the benefits of controls must be considered relative to their costs. Because of
the inherent limitations in all control systems, no evaluation of controls can
provide absolute assurance that all control issues and instances of fraud, if
any, within the company have been detected. These inherent limitations include
the realities that judgments in decision-making can be faulty, and that
breakdowns can occur because of simple error or mistake. Additionally, controls
can be circumvented by the individual acts of some persons, by collusion of two
or more people, or by management override of the control. The design of any
system of controls also is based in part upon certain assumptions about the
likelihood of future events, and there can be no assurance that any design will
succeed in achieving its stated goals under all potential future conditions;
over time, control may become inadequate because of changes in conditions, or
the degree of compliance with the policies or procedures may deteriorate.
Because of the inherent limitations in a cost-effective control system,
misstatements due to error or fraud may occur and not be detected.
Scope of the Controls Evaluation. The CEO/CFO evaluation of our Disclosure
Controls and our Internal Controls included a review of the controls' objectives
and design, our implementation of the controls and the effect of the controls on
the information generated for use in this Annual Report. In the course of the
Controls Evaluation, we sought to identify data errors, controls problems or
acts of fraud and to confirm that appropriate corrective action, including
process improvements, were being undertaken. This type of evaluation will be
done on a at least an annual basis so that the conclusions concerning controls
effectiveness can be reported in our Annual Reports on Form 10-K. Our Internal
Controls are also evaluated on an ongoing basis by other personnel in our
company and by our independent auditors in connection with their audit and
review activities. The overall goals of these various evaluation activities are
to monitor our Disclosure Controls and our Internal Controls and to make
modifications as necessary; our intent in this regard is that the Disclosure
Controls and the Internal Controls will be maintained as dynamic systems that
change (including with improvements and corrections) as conditions warrant.
Among other matters, we sought in our evaluation to determine whether there were
any "significant deficiencies" or "material weaknesses" in our Internal
Controls, or whether we had identified any acts of fraud involving personnel who
have a significant role in our Internal Controls. This information was important
both for the Controls Evaluation generally and because items 5 and 6 in the
Section 302 Certifications of the CEO and CFO require that the CEO and CFO
disclose that information to our Board's Audit Committee and to our independent
auditors and to report on related matters in this section of the Annual Report.
In the professional auditing literature, "significant deficiencies" are referred
to as "reportable conditions"; these are control issues that could have a
significant adverse effect on the ability to record, process, summarize and
report financial data in the financial statements. A "material weakness" is
defined in the auditing literature as a particularly serious reportable
condition where the internal control does not reduce to a relatively low level
the risk that misstatements caused by error or fraud may occur in amounts that
would be material in relation to the financial statements and not be detected
within a timely period by employees in the normal course of performing their
assigned functions. We also sought to deal with other controls matters in the
Controls Evaluation, and in each case if a problem was identified, we considered
what revision, improvement and/or correction to make in accord with our on-going
procedures.
In accord with SEC requirements, the CEO and CFO note that, since the date of
the Controls Evaluation to the date of this Annual Report, there have been no
significant changes in Internal Controls or in other factors that could
significantly affect Internal Controls, including any corrective actions with
regard to significant deficiencies and material weaknesses.
Conclusions. Based upon the Controls Evaluation, our CEO and CFO have concluded
that, subject to the limitations noted above, our Disclosure Controls are
effective to ensure that material information relating to us is made known to
management, including the CEO and CFO, particularly during the period when our
periodic reports are being prepared, and that our Internal Controls are
effective to provide reasonable assurance that our financial statements are
fairly presented in conformity with generally accepted accounting principles.
Item15. Exhibits, Financial Statement Schedules, and Reports on Form 8-K
(a)(1) Consolidated Financial Statements
The financial statements listed on the Index to Financial Statements
on page 30 are filed as part of this report on Form 10-K.
(a)(2) Financial Statement Schedules Required by Item 8
(a)(3) Exhibits
A listing of the exhibits to the Form 10-K is set forth on the
Exhibit Index which immediately precedes such exhibits in this Form
10-K.
(b) Reports on Form 8-K
UCI filed a Form 8-K on August 16, 2002 to report that the United
States Bankruptcy Court for the District of South Carolina had
confirmed plans of reorganization filed by UCI, its wholly-owned
subsidiaries, and certain of our affiliates in connection with such
entities' voluntary petition for protection under Chapter 11 of the
Bankruptcy Code.
UCI filed a Form 8-K on October 28, 2002 to report that UCI's Board of
Directors had approved an amendment to UCI's Amended and Restated
Bylaws dated November 23, 1993, as amended. Such amendment specifies
the procedure for business to be properly brought before an annual or
special meeting of stockholders and the process for nominations for the
election of directors to UCI's Board of Directors.
UCI filed a Form 8-K on November 13, 2002 to report that UCI's Board of
Directors appointed D. Michael Stout, MD as the President and Chief
Executive Officer of UCI.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Page(s)
Reports of Independent Accountants........................................................................31-32
Consolidated Balance Sheets at September 30, 2002 and 2001...................................................33
Consolidated Statements of Operations for the years
ended September 30, 2002, 2001 and 2000.............................................................34
Consolidated Statements of Changes in Stockholders' Equity
for the years ended September 30, 2002, 2001 and 2000...............................................35
Consolidated Statements of Cash Flows for the years
ended September 30, 2002, 2001 and 2000.............................................................36
Notes to Consolidated Financial Statements...............................................................37-52
Schedule II, Valuation and Qualifying Accounts, is omitted because the
information is included in the financial statements and notes.
Report of Independent Accountants
To the Board of Directors and
Stockholders of UCI Medical Affiliates, Inc.
Columbia, South Carolina
We have audited the accompanying consolidated balance sheets of UCI Medical
Affiliates, Inc. and its subsidiaries (the "Company") as of September 30, 2002
and 2001, and the related consolidated statements of operations, changes in
stockholders' equity, and cash flows for the years then ended. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of the Company as of
September 30, 2002 and 2001, and the results of its operations and its cash
flows for the years then ended in conformity with accounting principles
generally accepted in the United States of America.
As discussed in Note 1 to the consolidated financial statements, the Company
changed its method of accounting for goodwill and its method of reporting gains
and losses on the extinguishment of debt during the year ended September 30,
2002.
/S/ SCOTT MCELVEEN, L.L.P.
Columbia, South Carolina
November 26, 2002
..
SIGNED ORIGINAL ON SCOTT MCELVEEN LETTERHEAD
IS ON FILE IN THE CORPORATE OFFICE OF
UCI MEDICAL AFFILIATES, INC.
Report of Independent Accountants
To the Board of Directors and
Stockholders of UCI Medical Affiliates, Inc.:
In our opinion, the consolidated statements of operations, changes in
stockholders' equity and cash flows for the year ended September 30, 2000,
appearing on pages 34 through 36 of the UCI Medical Affiliates, Inc.'s 2002 Form
10-K, present fairly, in all material respects, the results of operations and
cash flows of UCI Medical Affiliates and its subsidiaries for the year ended
September 30, 2000, in conformity with accounting principles generally accepted
in the United States of America. These financial statements are the
responsibility of the Company's management; our responsibility is to express an
opinion on these financial statements based on our audit. We conducted our audit
of these statements in accordance with auditing standards generally accepted in
the United States of America, which require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free
of material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements, assessing
the accounting principles used and significant estimates made by management, and
evaluating the overall financial statement presentation. We believe that our
audit provides a reasonable basis for our opinion.
The consolidated statements of operations, changes in stockholders' equity and
cash flows for the year ended September 30, 2000 have been prepared assuming
that the Company will continue as a going concern. In 2000, the Company has a
current year net loss, an accumulated deficit, and a working capital deficiency.
These matters raise substantial doubt about the ability of the Company to
continue as a going concern. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
PricewaterhouseCoopers LLP
December 27, 2000
ORIGINAL SIGNED OPINION
IS ON FILE WITH
UCI MEDICAL AFFILIATES, INC
UCI Medical Affiliates, Inc.
Consolidated Balance Sheets
September 30,
-------------------------------------
2002 2001
----------------- ----------------
Assets
Current assets
Cash and cash equivalents $ 269,298 $ 99,429
Accounts receivable, less allowance for doubtful accounts
of $1,661,047 and $1,386,416 6,349,629 6,296,586
Inventory 393,795 360,560
Prepaid expenses and other current assets 297,178 833,732
----------------- ----------------
Total current assets 7,309,900 7,590,307
Property and equipment, less accumulated depreciation of
$8,149,811 and $7,128,248 3,764,545 3,977,014
Excess of cost over fair value of assets acquired, less
accumulated amortization of $2,451,814 3,391,942 3,391,942
Other assets 50,483 23,951
----------------- ----------------
Total Assets $ 14,516,870 $ 14,983,214
================= ================
Liabilities and Stockholders' Equity
Current liabilities
Book overdraft $ -- $ 733,094
Current portion of long-term debt 1,014,829 4,858,216
Accounts payable 762,646 2,801,450
Accrued salaries and payroll taxes 1,514,745 3,651,068
Current portion of pre-petition payroll taxes 475,079 --
Other accrued liabilities 1,027,299 1,790,931
----------------- ----------------
Total current liabilities 4,794,598 13,834,759
Long-term liabilities
Accounts payable 2,083,167 --
Long-term portion of pre-petition payroll taxes 4,385,060 --
Long-term debt, net of current portion 3,063,649 2,352,054
----------------- ----------------
Total long-term liabilities 9,531,876 2,352,054
----------------- ----------------
----------------- ----------------
Total Liabilities 14,326,474 16,186,813
----------------- ----------------
Commitments and contingencies (Note 12)
Stockholders' Equity
Preferred stock, par value $.01 per share:
Authorized shares - 10,000,000; none issued -- --
Common stock, par value $.05 per share:
Authorized shares - 50,000,000 and 10,000,000
Issued and outstanding- 9,650,515 and 9,650,515 shares 482,526 482,526
Paid-in capital 21,723,628 21,723,628
Accumulated deficit (22,015,758) (23,409,753)
----------------- ----------------
Total Stockholders' Equity (Deficiency) 190,396 (1,203,599)
----------------- ----------------
Total Liabilities and Stockholders' Equity $ 14,516,870 $ 14,983,214
================= ================
The accompanying notes are an integral part of these
consolidated financial statements.
UCI Medical Affiliates, Inc.
Consolidated Statements of Operations
For the Years Ended September 30,
-----------------------------------------------------------------
2002 2001 2000
------------------ ----------------- ------------------
Revenues $ 38,526,603 $ 38,117,161 $ 39,953,311
Operating costs 36,288,348 35,545,631 38,126,570
------------------ ----------------- ------------------
Operating margin 2,238,255 2,571,530 1,826,741
General and administrative expenses 76,241 50,293 86,025
Reorganization charges 214,968 -- --
Realignment and impairment charges -- 752,737 4,128,376
Depreciation and amortization 1,021,563 1,544,153 1,719,502
Gain on extinguishment of debt (2,704,920) -- --
------------------ ----------------- ------------------
------------------ ----------------- ------------------
Income (loss) from operations 3,630,403 224,347 (4,107,162)
------------------ ----------------- ------------------
------------------ ----------------- ------------------
Other expenses: Interest expense and other charges
(2,236,408) (1,698,948) (1,995,319)
------------------ ----------------- ------------------
------------------ ----------------- ------------------
Net income (loss) $ 1,393,995 $ (1,474,601) $ (6,102,481)
================== ================= ==================
================== ================= ==================
Earnings (loss) per common share:
Basic earnings (loss) per common share $.14 $(.15) $(.63)
================== ================= ==================
================== ================= ==================
Diluted earnings (loss) per common share $.14 $(.15) $(.63)
================== ================= ==================
================== ================= ==================
Basic weighted average common shares outstanding 9,650,515 9,650,515 9,650,515
================== ================= ==================
Diluted weighted average common shares outstanding $ 9,650,515 $ 9,650,515 $ 9,650,515
================== ================= ==================
The accompanying notes are an integral part of these
consolidated financial statements.
UCI Medical Affiliates, Inc.
Consolidated Statements of Changes in Stockholders' Equity
For the Three Years Ended September 30, 2002
Common Stock Paid-In Accumulated
--------------------------------
Shares Par Value Capital Deficit Total
---------------- ------------ --------------- ------------------- ----------------
---------------- ------------ --------------- ------------------- ----------------
Balance, September 30, 1999 9,650,515 $ 482,526 $ 21,723,628 $ (15,832,671) $ 6,373,483
Net loss -- -- -- (6,102,481) (6,102,481)
---------------- ------------ --------------- ------------------- ----------------
Balance, September 30, 2000 9,650,515 482,526 21,723,628 (21,935,152) 271,002
Net loss -- -- -- (1,474,601) (1,474,601)
---------------- ------------ --------------- ------------------- ----------------
Balance, September 30, 2001 9,650,515 482,526 21,723,628 (23,409,753) (1,203,599)
Net income -- -- -- 1,393,995 1,393,995
---------------- ------------ --------------- ------------------- ----------------
---------------- ------------ --------------- ------------------- ----------------
Balance, September 30, 2002 9,650,515 $482,526 $21,723,628 $(22,015,758) $ 190,396
================ ============ =============== =================== ================
The accompanying notes are an integral part of these
consolidated financial statements.
UCI Medical Affiliates, Inc.
Consolidated Statements of Cash Flows
For the Years Ended September 30,
-----------------------------------------------------------
2002 2001 2000
------------------ ----------------- ----------------
Operating activities:
Net income (loss) $1,393,995 $ (1,474,601) $(6,102,481)
Adjustments to reconcile net income (loss) to net
cash provided by operating activities:
Gain on extinguishment of debt (2,704,920) -- --
Provision for losses on accounts receivable 1,845,094 1,494,915 2,808,486
Depreciation and amortization 1,021,563 1,544,153 1,719,502
Non-cash realignment and impairment charges -- 752,737 3,567,376
(Increase) decrease in accounts receivable (1,898,137) (832,756) (1,367,488)
(Increase) decrease in inventory (33,235) 262,937 (33,179)
(Increase) decrease in prepaid expenses and other
current assets 536,554 99,398 (184,663)
Increase (decrease) in accounts payable and accrued
expenses 2,216,431 869,440 640,894
------------------ ----------------- ----------------
Cash provided by operating activities 2,377,345 2,716,223 1,048,447
------------------ ----------------- ----------------
Investing activities:
Purchases of property and equipment (809,094) (744,063) (857,609)
Disposals of property and equipment -- -- 156,845
(Increase) decrease in other assets (26,532) 17,549 --
------------------ ----------------- ----------------
Cash used in investing activities (835,626) (726,514) (700,764)
------------------ ----------------- ----------------
Financing activities:
Net (payments) borrowings under line-of-credit agreement (371,317) (826,202) 773,001
(Decrease) increase in book overdraft (733,094) (451,163) 381,000
Payments on long-term debt (267,439) (915,842) (1,264,916)
------------------ ----------------- ----------------
Cash used in financing activities (1,371,850) (2,193,207) (110,915)
------------------ ----------------- ----------------
Increase (decrease) in cash and cash equivalents 169,869 (203,498) 236,768
Cash and cash equivalents at beginning of year 99,429 302,927 66,159
------------------ -----------------
------------------ ----------------- ----------------
Cash and cash equivalents at end of year $ 269,298 $ 99,429 $ 302,927
================== ================= ================
The accompanying notes are an integral part of these
consolidated financial statements.
UCI MEDICAL AFFILIATES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Significant Accounting Policies
Basis of Presentation
The consolidated financial statements include the accounts of UCI Medical
Affiliates, Inc. ("UCI"), UCI Medical Affiliates of South Carolina, Inc.
(UCI-SC), UCI Medical Affiliates of Georgia, Inc. ("UCI-GA"), Doctor's Care,
P.A., Doctor's Care of Georgia, P.C., and Doctor's Care of Tennessee, P.C. (the
three together as the "P.A." and together with UCI, UCI-SC and UCI-GA, the
"Company"). Because of the corporate practice of medicine laws in the states in
which the Company operates, the Company does not own medical practices but
instead enters into exclusive long-term management services agreements with the
P.A. which operate the medical practices. Consolidation of the financial
statements is required under Emerging Issues Task Force (EITF) 97-2 as a
consequence of the nominee shareholder arrangement that exists with respect to
each of the P.A.'s. In each case, the nominee (and sole) shareholder of the P.A.
has entered into an agreement with UCI-SC or UCI-GA, as applicable, which
satisfies the requirements set forth in footnote 1 of EITF 97-2. Under the
agreement, UCI-SC or UCI-GA, as applicable, in its sole discretion, can effect a
change in the nominee shareholder at any time for a payment of $100 from the new
nominee shareholder to the old nominee shareholder, with no limits placed on the
identity of any new nominee shareholder and no adverse impact resulting to any
of UCI-SC, UCI-GA or the P.A. resulting from such change.
In addition to the nominee shareholder arrangements described above, each of
UCI-SC and UCI-GA have entered into Administrative Service Agreements with the
P.A.'s. As a consequence of the nominee shareholder arrangements and the
Administrative Service Agreements, the Company has a long-term financial
interest in the affiliated practices of the P.A.'s through the Administrative
Services Agreement, and the Company has exclusive authority over decision making
relating to all major on-going operations. The Company establishes annual
operating and capital budgets for the P.A. and compensation guidelines for the
licensed medical professionals. The Administrative Services Agreements have an
initial term of forty years. According to EITF 97-2, the application of
Financial Accounting Standards Board ("FASB") Statement No. 94 (Consolidation of
All Majority-Owned Subsidiaries), and FASB 141 (Business Combinations), the
Company must consolidate the results of the affiliated practices with those of
the Company. All significant intercompany accounts and transactions are
eliminated in consolidation, including management fees.
The method of computing the management fees are based on billings of the
affiliated practices less the amounts necessary to pay professional compensation
and other professional expenses. In all cases, these fees are meant to
compensate the Company for expenses incurred in providing covered services plus
a profit. These interests are unilaterally salable and transferable by the
Company and fluctuate based upon the actual performance of the operations of the
professional corporation.
The P.A. enters into employment agreements with physicians for terms ranging
from one to three years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license.
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and revenues and expenses
and the disclosure of contingent assets and liabilities. Actual results could
differ from those estimates and assumptions. Significant estimates are discussed
in these footnotes, as applicable.
Medical Supplies and Drug Inventory
The inventory of medical supplies and drugs is carried at the lower of average
cost (first in, first out) or market.
Property and Equipment
Property and equipment is recorded at cost.
Depreciation is provided principally by the straight-line method over the
estimated useful lives of the assets, ranging from three to thirty years.
Maintenance, repairs and minor renewals are charged to expense. Major renewals
or betterments, which prolong the life of the assets, are capitalized.
Upon disposal of depreciable property, the asset accounts are reduced by the
related cost and accumulated depreciation. The resulting gains and losses are
reflected in the consolidated statements of operations.
Intangible Assets
Effective October 1, 2001, the Company adopted Statement of Financial Accounting
Standards ("SFAS") No. 142, "Goodwill and Other Intangible Assets" ("SFAS No.
142"). Prior to the adoption of SFAS No. 142, costs in excess of net tangible
assets acquired were stated net of accumulated amortization and amortized on a
straight-line basis over periods not exceeding 15 years. Under SFAS No.142,
goodwill and intangible assets with indefinite useful lives are no longer
amortized but rather reviewed for impairment annually, or more frequently if
certain indicators arise. Other indicators of a permanent impairment include,
among other things, significant adverse change in legal factors or the business
climate, an adverse action by a regulator, unanticipated competition, and loss
of key personnel or allocation of goodwill to a portion of business that is to
be sold. Intangible assets with definite useful lives are amortized over their
respective estimated useful lives to their estimated residual values, and also
reviewed for impairment annually, or more frequently if certain indicators
arise, in accordance with SFAS No. 121, "Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed of" (SFAS No. 121").
In performing the annual impairment test, the Company compares the fair value of
the Company, as determined by the current market value of the common stock, to
the carrying value of the total assets, including goodwill and intangible
assets. The Company completed the transitional impairment analysis and
determined that no impairment existed at the time of the adoption of SFAS No.
142. Any subsequent impairment losses will be reflected in operating income in
the income statement in the period in which the impairment is determined. The
Company completed its annual impairment test on September 30, 2002 and
determined that no impairment existed. Accordingly, no impairment charges were
required.
Had the Company accounted for its goodwill and other intangible assets not
subject to amortization under SFAS No. 142 for all periods presented, the
Company's net income (loss) and earnings (loss) per share would have been as
follows:
Year Ended September 30,
--------------------------------------------------------------
----------------- --- ------------------ --- -----------------
2002 2001 2000
----------------- ------------------ -----------------
-----------------
Reported net income (loss) $ 1,393,995 $ (1,474,601) $ (6,102,481)
Add back amortization of intangible assets no
longer subject to amortization -- 381,459 551,826
----------------- ------------------ -----------------
----------------- ------------------ -----------------
Adjusted net income (loss) 1,393,995 (1,093,142) (5,550,655)
================= ================== =================
================= ================== =================
Basic and diluted earnings per share:
Reported net income (loss) $ .14 $ (.15) $ (.63)
Goodwill amortization -- .04 .06
----------------- ------------------ -----------------
----------------- ------------------ -----------------
Adjusted net earnings (loss) per share $ .14 $ (.11) $ (.57)
================= ================== =================
Revenue Recognition
Revenue is recognized at estimated net amounts to be received from employers,
third party payors, and others at the time the related services are rendered.
The Company records contractual adjustments at the time bills are generated for
services rendered. Third parties are billed at the discounted amounts. As such,
estimates of outstanding contractual adjustments or any type of third party
settlements of contractual adjustments are not necessary.
Advertising Costs
Advertising and marketing costs are expensed as incurred. Advertising and
marketing costs were approximately $230,000, $228,000 and $246,000,
respectively, for the three fiscal years ended September 30, 2002.
Income (Loss) Per Share
The computation of basic income (loss) per share is based on the weighted
average number of common shares outstanding during the period. Diluted income
per share is similar to basic income (loss) per share except that the weighted
average common shares outstanding is increased to include the number of shares
that would have been outstanding had the dilutive potential common shares been
issued, such as common stock options and warrants.
Income Taxes
Deferred tax assets and liabilities are recorded based on the difference between
the financial statement and tax bases of assets and liabilities as measured by
the enacted tax rates which are anticipated to be in effect when these
differences reverse. The deferred tax provision is the result of the net change
in the deferred tax assets to amounts expected to be realized. Valuation
allowances are provided against deferred tax assets when the Company determines
it is more likely than not that the deferred tax asset will not be realized.
Extinguishments of Debt
In April 2002, the Financial Accounting Standards Board issued SFAS No. 145
("SFAS No. 145"), which, among other things, rescinded SFAS No. 4, "Reporting
Gains and Losses from Extingusihment of Debt" ("SFAS No. 4"). Previously under
SFAS No. 4, all gains and losses from extinguishments of debt were required to
be aggregated and, if material, classified as an extraordinary item only if they
meet the criteria in APB Opinion No. 30, "Reporting the Results of
Operations-Reporting the Effects of Disposal of a Segment of a Business, and
Extraordinary, Unusual and Infrequently Occurring Events and Transactions"
("Opinion No. 30"). Any gain or loss on extinguishments of debt that were
presented as extraordinary items in prior periods but which do not qualify for
classification as an extraordinary item under Opinion No. 30, are to be
reclassified. Companies are required to adopt SFAS No. 145 in fiscal years
beginning after May 15, 2002 but may elect to early adopt.
The Company elected to adopt the provisions of SFAS No.145 during the fourth
quarter of fiscal year 2002. The Company had no extinguishments of debt
presented as an extraordinary item in prior periods and therefore, no
reclassifications were necessary.
Cash and Cash Equivalents
The Company considers all short-term deposits with a maturity of three months or
less at acquisition date to be cash equivalents.
Fair Value of Financial Instruments
The estimated fair value of financial instruments has been determined by the
Company using available market information and appropriate valuation
methodologies. However, considerable judgment is required in interpreting data
to develop the estimates of fair value. Accordingly, the estimates presented
herein are not necessarily indicative of the amounts that the Company could
realize in a current market exchange. The fair value estimates presented herein
are based on pertinent information available to management as of September 30,
2002 and 2001. Although management is not aware of any factors that would
significantly affect the estimated fair value amounts, such amounts have not
been comprehensively revalued for purposes of these financial statements since
that date and current estimates of fair value may differ significantly from the
amounts presented herein. The fair values of the Company's financial instruments
are estimated based on current market rates and instruments with the same risk
and maturities. The fair values of cash and cash equivalents, accounts
receivable, accounts payable, notes payable and payables to related parties
approximate the carrying values of these financial instruments.
Segment Information
UCI adopted FASB Statement of Financial Accounting Standards No. ("SFAS") 131,
"Disclosure about Segments of an Enterprise and Related Information," in fiscal
year 1999. SFAS No. 131 requires companies to report financial and descriptive
information about their reportable operating segments, including segment profit
or loss, certain specific revenue and expense items, and segment assets, as well
as information about the revenues derived from the Company's products and
services, the countries in which the Company earns revenues and holds assets,
and major customers. This statement also requires companies that have a single
reportable segment to disclose information about products and services,
information about geographic areas, and information about major customers. This
statement requires the use of the management approach to determine the
information to be reported. The management approach is based on the way
management organizes the enterprise to assess performance and make operating
decisions regarding the allocation of resources. It is management's opinion
that, at this time, UCI has several operating segments, however, only one
reportable segment. The following discussion sets forth the required disclosures
regarding single segment information.
UCI provides nonmedical management and administrative services for a network of
36-freestanding medical centers, 34 of which are located throughout South
Carolina and two are located in Knoxville, Tennessee (29 operating as Doctor's
Care in South Carolina, one as Doctor's Care in Knoxville, Tennessee, five as
Progressive Physical Therapy Services in South Carolina, and one as Progressive
Physical Therapy Services in Knoxville, Tennessee).
Recent Pronouncements
In August 2001, the Financial Accounting Standards Board issued SFAS No.
144, "Accounting for the Impairment or Disposal of Long-Lived Assets" ("SFAS No.
144"). SFAS No. 144 supersedes SFAS No. 121 and the accounting and reporting
provisions of Opinion No. 30 as they relate to the disposal of a segment of a
business (as previously defined in that Opinion). SFAS No. 144 retains the
requirements for SFAS No. 121 to (a) recognize an impairment loss if the
carrying amount of a long-lived asset is not recoverable from its undiscounted
cash flows and (b) measure an impairment loss as the difference between the
carrying amount and fair value of the asset. However, SFAS No. 144 addresses
various implementation issues not addressed by SFAS No. 121 or Opinion No. 30.
This statement is effective for years beginning after December 15, 2001. The
adoption of this new accounting standard is not expected to have a material
impact on the Company's consolidated financial position or results of operation.
2. Chapter 11 Bankruptcy Filing
On November 2, 2001, the Company (the "Debtors") filed a voluntary petition for
reorganization under Chapter 11 of the United States Bankruptcy Code (the
"Bankruptcy Code") in the United States Bankruptcy Court for the District of
South Carolina (the "Bankruptcy Court"). As debtor-in-possession, the Company
remains in possession of their properties and assets and management of the
Company continues to operate the business of the Debtors.
The Bankruptcy Court approved payment of certain pre-petition liabilities, such
as employee wages and benefits, and settlement of certain trade payable claims.
In addition, the Bankruptcy Court allowed for the retention of legal and
financial professionals to advise in the bankruptcy proceedings.
The Company's Plans of Reorganization, as amended, were confirmed by the Court
by August 8, 2002 and the Company has, therefore, emerged from the Chapter 11
protection of the Court.
Because holders of our existing voting shares immediately before confirmation
received more than 50% of the voting shares of the reorganized equity, the
Company did not qualify for fresh start accounting under SOP 90-7.
The more significant transactions resulting from the reorganization under
Chapter 11 are as follows:
Accrued Other
Accounts Long-Term Debt Payroll Taxes Accrued
Payable Liabilities
-------------- ---------------- -------------- --------------
-------------- ---------------- -------------- --------------
Pre-petition liability amounts, net of any
payments made during the reorganization
period, as approved by the Bankruptcy
Court 2,537,379 6,571,513 - 1,777,618
-------------- ---------------- -------------- --------------
-------------- ---------------- -------------- --------------
Adjustments; as a result of Chapter 11:
Conversion of unsecured notes payable to
accounts payable to be paid at 0% interest
over 72 months (interest imputed at 8%
per annum) 993,035 (993,035) - -
Present value adjustment of accounts payable to be paid at 0% interest over 72
months (interest imputed at 8% per
annum) (684,601) - - -
Forgiveness of convertible debenture and
interest payable to FPA - (1,500,000) - (291,919)
Rejected executory contracts (Atlanta
leases) under Chapter 11 - - - (228,400)
Reclassification of accrued interest and
penalties to pre-petition payroll tax - -
liability 230,000 (230,000)
Reclassification of delinquent payroll taxes
from accrued salaries and payroll taxes to
pre-petition payroll tax liability - - 2,373,467 -
Interest and penalties assessment by taxing
authorities under Chapter 11 - - 2,256,672 -
-------------- ---------------- -------------- --------------
-------------- ---------------- -------------- --------------
Total adjustments 308,434 (2,493,035) 4,860,139 (750,319)
-------------- ---------------- -------------- --------------
-------------- ---------------- -------------- --------------
Confirmed liability 2,845,813 4,078,478 4,860,139 1,027,299
Less current portion (762,646) (1,014,829) (475,079) (1,027,299)
-------------- ---------------- -------------- --------------
-------------- ---------------- -------------- --------------
Non-current portion $2,083,167 $3,063,649 $4,385,060 $ -
============== ================ ============== ==============
As a result of the Chapter 11 reorganization, the Company recorded a gain on
extinguishment of debt in the approximate amount of $2,705,000, which resulted
from a discharge of a $1,500,000 of convertible subordinated debenture with
accrued interest of approximately $292,000; reducing the carrying value of
compromised accounts payable balance to their current present value by
approximately $685,000; and the termination of certain leases, with a recorded
balance of approximately $228,000.
3. Property and Equipment
Property and equipment consists of the following at September 30:
September 30, 2002 September 30, 2001
---------------------------------- -----------------------------
Useful Life
Range Accumulated Accumulated
(in years) Cost Depreciation Cost Depreciation
------------- --------------- ---------------- --------------- ---------------
- ------------------------------ ------------- --------------- ---------------- --------------- ---------------
5-30 $ 412,750 $ 102,199 $ 412,750 $ 88,656
Building
N/A 66,000 -- 66,000 --
Land
5-15 1,745,873 1,258,058 1,623,176 1,069,213
Leasehold Improvements
1-5 1,592,579 1,275,411 1,555,451 1,124,669
Furniture & Fixtures
1-5 1,402,274 1,238,807 1,402,274 1,122,277
EDP - Companion
1-5 1,231,179 855,691 1,032,053 743,740
EDP - Other
5-10 4,135,356 2,539,229 3,765,883 2,255,019
Medical Equipment
1-5 1,260,765 844,020 1,212,576 693,857
Other Equipment
Autos 3-10 67,580 36,396 35,099 30,817
--------------- ---------------- --------------- ---------------
$11,914,356 $8,149,811 $11,105,262 $7,128,248
Totals
=============== ================ =============== ===============
At September 30, 2002 and 2001, capitalized leased equipment included above
amounted to approximately $728,000 and $1,414,000, net of accumulated
amortization of $515,751 and $841,000, respectively.
Depreciation expense equaled $1,021,563, $1,162,694, and $1,167,676 for the
years ended September 30, 2002, 2001, and 2000, respectively.
4. Income Taxes
The components of the provision for income taxes for the years ended September
30 are as follows:
2002 2001
------------- ---------------
Deferred:
$ -- $ --
Federal
-- --
State
------------- ---------------
$ -- $ --
Total income tax expense
============= ===============
Deferred taxes result from temporary differences in the recognition of certain
items of income and expense, and the changes in the valuation allowance
attributable to deferred tax assets.
At September 30, 2002, 2001, and 2000, the Company's deferred tax assets
(liabilities) and the related valuation allowances are as follows:
2002 2001 2000
----------------- ----------------- -----------------
----------------- -----------------
$ 614,587 $ 512,974 $ 573,148
Accounts receivable
17,808 15,950 12,283
Other
6,223,974 6,890,796 7,402,625
Operating loss carry forwards
(370,791) (411,518) (429,151)
Fixed assets
Accruals 131,157 56,808 82,655
----------------- -----------------
----------------- ----------------- -----------------
$ 6,616,735 $ 7,065,010 $ 7,641,560
Available deferred tax assets
================= ================= =================
================= =================
$ 6,616,735 $ 7,065,010 $ 7,641,560
Valuation allowance
================= ================= =================
The principal reasons for the differences between the consolidated income tax
(benefit) expense and the amount computed by applying the statutory federal
income tax rate of 34% to pre-tax income were as follows for the years ended
September 30:
2002 2001 2000
---------------- --------------- ----------------
$ 473,958 $ (501,364) $ (1,964,344)
Tax at federal statutory rate
Effect on rate of:
(60,919) 119,935 730,838
Amortization of goodwill
30,041 106,244 21,377
Non deductible expenses
(18,504) -- --
Other
23,699 (24,281) (106,953)
State income taxes & other
(448,275) 299,466 1,319,082
Change in valuation allowance
---------------- --------------- ----------------
$ -- $ -- $ --
================ =============== ================
At September 30, 2002, the Company has net tax operating loss (NOL)
carryforwards expiring in the following years ending September 30,
2003 458,112
2005 470,006
2006 76,306
2010 1,944,371
2012 645,206
2018
2,908,607
2019 4,839,897
2020 4,494,758
2021 984,289
----------------
$16,821,552
================
During the year ended September 30, 1996, the Company experienced an ownership
change, which limits the amount of net operating losses the Company may use on
an annual basis for income tax purposes for years with NOL's that expire prior
to 2011. The Company may use up to $893,507 of net operating losses on an annual
basis.
In determining that it was more likely than not that the recorded deferred tax
asset would not be realized, management of the Company considered the following:
o Recent historical operations results.
o The budgets and forecasts that management and the Board of Directors had
adopted for the next fiscal year. o The ability to utilize NOL's prior to their
expiration. o The potential limitation of NOL utilization in the event of a
change in ownership. o The generation of future taxable income in excess of
income reported on the consolidated financial statements.
A valuation allowance of approximately $6.6 million and $7.1 million at
September 30, 2002 and 2001, respectively, remained necessary in the judgement
of management because the factors noted above did not support the utilization of
less than a full valuation allowance.
5. Long-Term Debt
Long-term debt consists of the following at September 30:
2001
2002
----------------- -----------------
Term note in the amount of $2,407,501 dated August 28, 2002, payable in monthly
installments of principal and interest at a rate of prime plus 2% (prime rate is
4.75% as of September 30, 2002), maturing August 2005,
collateralized by substantially all assets of the Company. $2,253,520 $2,624,837
Convertible subordinated debenture (to the Company's common stock at $3.20
per share) in the amount of $1,500,000, dated October 6, 1997, interest
only payable annually at the rate of 6.5%, maturing October 5, 2002. This
debt was eliminated as part of the Company's Reorganization. -- 1,500,000
Note payable in the amount of $1,600,000 with monthly installments of $13,328
plus interest at prime plus 2% (prime rate is 4.75 % as of
September 30, 2002), through January 1, 2009 collateralized by accounts 800,618 808,555
receivable from patients and leasehold interests and the guarantee of the
P.A.
Note payable to MainStreet Healthcare Corporation in the amount of $800,000
dated August 31, 1998, payable in monthly installments of $5,293 maturing
January 31, 2008. This debt was found to be unsecured and was
placed on accounts payable and will be paid over a 72 month period. -- 374,109
Note payable to a financial institution in the amount of $500,000, dated April
17, 2000, payable in monthly installments of principal and interest at a rate of
prime plus 1% (prime rate is 4.75% as of September 30, 2002) maturing on May 2,
2004, collateralized by common stock of the Company owned by the former
President of the Company as well as a life insurance
policy on the president of the Company. 165,139 267,222
Note payable to Companion Property & Casualty Insurance Company (a shareholder)
in the amount of $400,000, with monthly installments of $4,148 from August 1,
2002 to January 1, 2009, collateralized by accounts
receivable from patients. This debt was found to be unsecured and was -- 298,635
placed on accounts payable and will be paid out over a 72 month period.
Note payable to a financial institution in the amount of $280,000, dated May 11,
2002, with monthly installments (including interest at a variable rate of prime
plus 1.5%) (prime rate is 4.75% as of September 30, 2002) of $2,377 from May
2002 to April 2005, with a final payment of all remaining
principal and accrued interest due in April 2005, collateralized by a 204,723 221,075
mortgage on one of the Company's medical facilities with a net book value
of approximately $405,000.
2001
2002
----------------- -----------------
Note payable to a financial institution in the amount of $194,782, payable in
monthly installments of $2,020.82 maturing on January 1, 2009, personally
guaranteed by three former physician employees of the P.A.
This note was found to be unsecured and was placed on accounts payable and -- 167,391
will be paid over 72 months.
----------------- -----------------
----------------- -----------------
3,424,000 6,261,824
Subtotal
654,478 948,446
Capitalized lease obligations
----------------- -----------------
4,078,478 7,210,270
(1,014,829) (4,858,216)
Less, current portion
----------------- -----------------
$3,063,649 $2,352,054
================= =================
Aggregate maturities of notes payable and capital leases are as follows:
Notes Payable Capital Leases
Year ending September 30: Total
---------------- ---------------- ----------------
$ 806,077 $208,752 $1,014,829
2003
767,051 158,311 925,362
2004
703,994 153,180 857,174
2005
653,514 134,235 787,749
2006
127,994 -- 127,994
2007
365,370 -- 365,370
Thereafter
---------------- ---------------- ----------------
$3,424,000 $654,478 $4,078,478
================ ================ ================
6. Employee Benefit Plans
The Company has an employee savings plan (the Savings Plan) that qualifies as a
deferred salary arrangement under Section 401(k) of the Internal Revenue Code.
Under the Savings Plan, participating employees may defer a portion of their
pretax earnings, up to the Internal Revenue Service annual contribution limit.
The Company matches 100% of each employee's contribution up to a maximum of 4%
of the employee's earnings. The Company's matching contributions were
approximately $233,000, $226,000, and $221,000 in fiscal years 2002, 2001, and
2000, respectively.
During June 1997, the Company's Board of Directors approved the UCI/Doctor's
Care Deferred Compensation Plan (the "Plan") for key employees of the Company
with an effective date of June 1998. To be eligible for the Plan, key employees
must have completed three years of full-time employment and hold a management or
physician position that is required to obtain specific operational goals that
benefit the Company as a whole. Under the Plan, key employees may defer a
portion of their after tax earnings with the Company matching two times the
employee's contribution percentage. The Company's matching contribution were
approximately $161,000, $114,000, and $65,000 in fiscal years 2002, 2001, and
2000, respectively.
During the fiscal year ended September 30, 1984, the Company adopted an
incentive stock plan (the "1984 Plan"). The 1984 Plan expired under its terms in
December 1993. At September 30, 2002, there were stock options outstanding under
the 1984 Plan for 9,300 shares at $.25 per share, all of which were exercisable.
Pursuant to the Company's incentive stock option plan adopted in 1994, (the 1994
Plan), incentive stock options, within the meaning of Section 422 of the
Internal Revenue Code, may be granted to employees of the Company. The 1994 Plan
provides for the granting of options for the purchase of 750,000 shares at 100%
of the fair market value of the stock at the date of grant (or for 10% or higher
shareholders, at 110% of the fair market value of the stock at the date of
grant). Options granted under the 1994 Plan vest at a rate of 33% in each of the
three years following the grant. Vested options become exercisable one year
after the date of grant and can be exercised within ten years of the date of
grant, subject to earlier termination upon cessation of employment.
During the fiscal year ended September 30, 1996, the Company adopted a
Non-Employee Director Stock Option Plan (the 1996 Non-Employee Plan). The 1996
Non-Employee Plan provides for the granting of options to two non-employee
directors for the purchase of 10,000 shares of the Company's common stock at the
fair market value as of the date of grant. Under this plan, 5,000 options were
issued to Harold H. Adams, Jr. and 5,000 options were issued to Russell J.
Froneberger. These options are exercisable during the period commencing on March
20, 1999 and ending on March 20, 2006.
During the fiscal year ended September 30, 1997, the Company adopted a
Non-Employee Director Stock Option Plan (the 1997 Non-Employee Plan). The 1997
Non-Employee Plan provides for the granting of options to four non-employee
directors for the purchase of 20,000 shares of the Company's common stock at the
fair market value of the date of grant. Under this plan, 5,000 options were
issued and are outstanding as of September 30, 1998 to Thomas G. Faulds, Ashby
Jordan, M.D., and Charles M. Potok. These options are exercisable during the
period commencing on March 28, 2000 and ending on March 28, 2007.
7. Stockholders' Equity
In February 1999, the shareholders approved an increase in the number of
authorized shares to 50,000,000. The following table summarizes activity and
weighted average fair value of options granted for the three previous fiscal
years for the Company's four stock option plans.
1996
Non-Employee 1997
1984 1994 Plan Non-Employee
Stock Options Plan Plan Plan
- ----------------------------- ----------- ----------- -----------
----------
Outstanding at 09/30/99 582,825
11,600 10,000 15,000
---------- ----------- ----------- -----------
Exercisable at 09/30/99 582,825 10,000 15,000
11,600
Forfeited FY 99/00 (500) (17,500) -- --
----------- ----------- -----------
---------- ----------- ----------- -----------
Outstanding at 09/30/00 11,100 565,325 10,000 15,000
---------- ----------- ----------- -----------
Exercisable at 09/30/00 11,100 565,325 10,000 15,000
Forfeited FY 00/01 -- -- -- --
---------- ----------- ----------- -----------
Outstanding at 09/30/01 11,100 565,325 10,000 15,000
---------- ----------- ----------- -----------
Exercisable at 09/30/01 11,100 565,325 10,000 15,000
Forfeited FY 01/02 (1,800) (224,675) -- --
---------- ----------- ----------- -----------
---------- ----------- ----------- -----------
Outstanding at 09/30/02 9,300 340,650 10,000 15,000
---------- ----------- ----------- -----------
---------- ----------- ----------- -----------
Exercisable at 09/30/02 9,300 340,650 10,000 15,000
---------- ----------- ----------- -----------
The Company has not granted options under any plans during fiscal years 2002,
2001, and 2000 and there have been no shares exercised during 2002, 2001, or
2000.
The following table summarizes the weighted average exercise price of stock
options exercisable at the end of each of the three previous fiscal years:
1996 1997
Weighted Average Non-Employee Plan Non-Employee
Exercise Price 1984 Plan 1994 Plan Plan
- ------------------------------------- ------------- ------------- ------------------ ------------------
Outstanding at 09/30/99 0.25 2.6475 3.50 2.50
------------- ------------- ------------------ ------------------
Exercisable at 09/30/99 0.25 2.6475 3.50 2.50
------------- ------------- ------------------ ------------------
Granted FY 99/00 -- -- -- --
Exercised FY 99/00 -- -- -- --
Forfeited FY 99/00 .25 3.04 -- --
------------- ------------- ------------------ ------------------
------------- ------------- ------------------ ------------------
Outstanding at 09/30/00 .25 2.63 3.50 2.50
------------- ------------- ------------------ ------------------
Exercisable at 09/30/00 .25 2.63 3.50 2.50
------------- ------------- ------------------ ------------------
Granted FY 00/01 -- -- -- --
Exercised FY 00/01 -- -- -- --
Forfeited FY 00/01 -- -- -- --
------------- ------------- ------------------ ------------------
Outstanding at 09/30/01 .25 2.63 3.50 2.50
------------- ------------- ------------------ ------------------
Exercisable at 09/30/01 .25 2.63 3.50 2.50
------------- ------------- ------------------ ------------------
------------- ------------- ------------------ ------------------
Granted FY 01/02 -- -- -- --
Exercised FY 01/02 -- -- -- --
Forfeited FY 01/02 .25 2.63 -- --
------------- ------------- ------------------ ------------------
------------- ------------- ------------------ ------------------
Outstanding at 09/30/02 .25 2.63 3.50 2.50
------------- ------------- ------------------ ------------------
------------- ------------- ------------------ ------------------
Exercisable at 09/30/02 .25 2.63 3.50 2.50
------------- ------------- ------------------ ------------------
The following table summarizes options outstanding and exercisable by price
range as of September 30, 2002:
Options Outstanding Options Exercisable
- -------------------- --- --------------------------------------------------- -- ------------------------------
Weighted
Average Weighted Weighted
Remaining Average Average
Contractual Exercise Exercise
Range of Price Outstanding Life Price Exercisable Price
- -------------------- --------------- --------------- ------------ -------------- ------------
9,300 2.25 .25 9,300 .25
$0.00 to $ .99
149,650 6.67 1.94 149,650 1.94
$1.00 to $1.99
137,000 3.72 2.56 137,000 2.56
$2.00 to $2.99
69,000 3.65 3.35 69,000 3.35
$3.00 to $3.99
10,000 1.68 4.28 10,000 4.28
$4.00 to $4.99
--------------- --------------
374,950 374,950
=============== ==============
The Company has adopted the disclosure-only provisions of SFAS No. 123,
Accounting for Stock-Based Compensation. Accordingly, no compensation cost has
been recognized for the stock option plans. Had compensation costs for the
Company's stock option plans been determined based on the fair value at the
grant date for awards in fiscal 2002, 2001 and 2000 consistent with the
provisions of SFAS No. 123, the Company's net income and earnings per share
would have been reduced to the pro forma amounts indicated below. The fair value
of each option granted is estimated on the date of grant using the Black-Scholes
option-pricing model.
Fiscal Year Ended September 30
--------------------------------------------------------
2002 2001 2000
------------- ------------------ -----------------
$1,393,995 $(1,474,601) $(6,102,481)
Net income (loss) - as reported
1,393,995 (1,474,601) (6,147,481)
Net income (loss) - pro forma
Basic and diluted earnings (loss) per .14 (.15) (.63)
share - as reported
Basic and diluted earnings (loss) per
share - pro forma .14 (.15) (.64)
9,650,515 9,650,515 9,650,515
Basic weighted average number of shares
Diluted weighted average number of shares 9,650,515 9,650,515 9,650,515
The fair value of each option granted is estimated on the date of grant using
the Black-Scholes option-pricing model with the following assumptions:
Zero
Expected Dividend Yield
35.77%
Expected Stock Price Volatility
5.45% to 6.75%
Risk-free Interest Rate
1 - 5 years
Expected Life of Options
During the year ended September 30, 1997, warrants for the purchase of shares of
the Company's common stock were issued, ranging in exercise price from $1.9375
to $5.00. Fifty-five thousand (55,000) warrants were issued in connection with
services to be rendered by an investor relations advisor to the Company. During
the years ended September 30, 1998 and September 30, 1999, the Company granted
to the convertible debenture holder warrants to purchase up to thirty-five
thousand (35,000) and ten thousand (10,000) warrant shares, respectively, as
part of a $1,500,000 convertible subordinated debenture. The Stock Purchase
Warrant allows for 65,000 shares in total. In addition, during the year ended
September 30, 1999, the Company granted to Allen & Company Incorporated,
financial advisors, warrants to purchase 150,000 shares of common stock. No
warrants were issued during the three fiscal years ended September 30, 2002.
The following is a schedule of warrants issued and outstanding during the years
ended September 30, 2002, 2001 and 2000:
Number of Exercise Date Expiration
Warrants Price Exercisable Date
-------------- --------------- --------------- --------------
--------------
Outstanding at 09/30/99 235,000
Activity during FY 99/00:
Exercised --
Expired --
--------------
Outstanding at 09/30/00 235,000
Activity during FY 00/01:
Exercised --
Expired (75,000) 2.5625 09/30/01 09/30/01
--------------
Outstanding at 09/30/01 160,000
--------------
--------------
Activity during FY 01/02:
Exercised --
Expired (10,000) 2.5625 10/06/00 08/08/02
--------------
--------------
Outstanding at 09/30/02 150,000
==============
8. Lease Commitments
UCI-SC leases office and medical center space under various operating lease
agreements. Certain operating leases provide for escalation payments, exclusive
of renewal options.
Future minimum lease payments under noncancellable operating leases with a
remaining term in excess of one year as of September 30, 2002, are as follows:
Operating
Leases
----------------
Year ending September 30:
$ 2,584,202
2003
2,544,096
2004
2005 2,540,450
2006 2,540,450
2007 2,519,506
20,184,270
Thereafter
----------------
$32,912,974
Total minimum lease payments
================
Total rental expense under operating leases for fiscal 2002, 2001, and 2000 was
approximately $2,600,000, $2,900,000 and $2,700,000, respectively.
9. Related Party Transactions
Relationship between UCI-SC and UCI-GA and the P.A.s
Pursuant to agreements between UCI-SC, UCI-GA and the P.A.'s, UCI-SC and UCI-GA
provide non-medical management services and personnel, facilities, equipment and
other assets to the medical centers. UCI-SC and UCI-GA guarantee the
compensation of the physicians employed by the P.A.'s. The agreements also allow
UCI-SC and UCI-GA to negotiate contracts with HMOs and other organizations for
the provision of medical services by the P.A.'s physicians. Under the terms of
the agreement, the P.A.'s assign all revenue generated from providing medical
services to UCI-SC or UCI-GA after paying physician salaries and the cost of
narcotic drugs held by the P.A.'s. P.A.'s are owned by D. Michael Stout, M.D.,
who is also the Chief Executive Officer for UCI, UCI-SC and UCI-GA.
Relationship between the Company and Blue Cross Blue Shield of South Carolina
Blue Cross Blue Shield of South Carolina (BCBS) owns 100% of Companion
HealthCare Corporation ("CHC"), Companion Property & Casualty Insurance Company
(CP&C) and Companion Technologies, Inc. ("CT"). At September 30, 2002, CHC owned
2,006,442 shares of the Company's outstanding common stock and CP&C owned
618,181 shares of the Company's outstanding common stock, which combine to
approximately 27% of the Company's outstanding common stock.
Facility Leases
Several of the medical center facilities operated by UCI-SC are leased or were
leased from entities owned or controlled by certain principal shareholders,
Board members, and/or members of the Company's management. Total lease payments
made by UCI-SC under these leases during the fiscal years ended September 30,
2002, 2001 and 2000 were approximately $96,000, $153,000, and $153,000,
respectively.
One medical facility operated by UCI-SC is or was leased from physician
employees of the P.A.'s. Total lease payments made by UCI-SC under these leases
during the Company's fiscal years ended September 30, 2002, 2001, and 2000 were
approximately $50,000, $49,000, and $49,000, respectively.
Other Transactions with Related Parties
At September 30, 2002, BCBS and its subsidiaries control 2,624,623 shares, or
approximately 27% of the Company's outstanding common stock. The shares acquired
by CHC and CP&C from the Company were purchased pursuant to stock purchase
agreements and were not registered. CHC and CP&C have the right to require
registration of the stock under certain circumstances as described in the
agreement. BCBS and its subsidiaries have the option to purchase as many shares
as may be necessary for BCBS to obtain ownership of 47% of the outstanding
common stock of the Company in the event that the Company issues additional
stock to other parties (excluding shares issued to employees or directors of the
Company).
The Company enters into capital lease obligations with CT to purchase computer
equipment, software, and billing and accounts receivable upgrades. The total of
all lease obligations to CT recorded at September 30, 2002 is $546,000.
During the Company's fiscal year ended September 30, 1994, UCI-SC entered into
an agreement with CP&C pursuant to which UCI-SC, through the P.A., acts as the
primary care provider for injured workers of firms carrying worker's
compensation insurance through CP&C.
UCI-SC, through the P.A., provides services to members of a health maintenance
organization (HMO) operated by CHC who have selected the P.A. as their primary
care provider.
During fiscal years 2002, 2001, and 2000, the Company paid BCBS and its
subsidiaries approximately $314,000, $110,000, and $170,000, respectively, in
interest.
Revenues generated from billings to BCBS and its subsidiaries totaled
approximately 29%, 26%, and 18% of the Company's total revenues for fiscal years
2002, 2001, and 2000.
10. Income (Loss) Per Share
All warrants and options to purchase shares of common stock were excluded from
the calculation at September 30, 2002, 2001, and 2000, respectively, because of
their antidilutive effect.
11. Concentration of Credit Risk
In the normal course of providing health care services, the Company may extend
credit to patients without requiring collateral. Each individual's ability to
pay balances due the Company is assessed and reserves are established to provide
for management's estimate of uncollectible balances. Approximately 6% of the
Company's year end accounts receivable balance is due from Blue Cross Blue
Shield of South Carolina. No other single payor represents more than 5% of the
year end balance.
Future revenues of the Company are largely dependent on third-party payors and
private insurance companies, especially in instances where the Company accepts
assignment.
12. Commitments and Contingencies
The Company is insured for professional and general liability on a claims-made
basis, with additional tail coverage being obtained when necessary.
The Company provides health benefits to its employees under a self-insured
health plan. Claims are paid by the Company up to an individual and aggregate
amount limit of $45,000 and $1,078,508, respectively. Claims in excess of these
limits are covered by a third-party insurance contract. Health benefit expenses
of approximately $938,000, $938,000, and $662,000, respectively, for the three
fiscal years ending September 30, 2002, are included in these financial
statements.
In the ordinary course of conducting its business, the Company becomes involved
in litigation, claims, and administrative proceedings. Certain litigation,
claims, and proceedings were pending at September 30, 2002, and management
intends to vigorously defend the Company in such matters.
The health care industry is subject to numerous laws and regulations of federal,
state and local governments. These laws and regulations include, but are not
necessarily limited to, matters such as licensure, accreditation, government
health care program participation requirements, reimbursement for patient
services and Medicare and Medicaid fraud and abuse. Recently, government
activity has increased with respect to investigations and allegations concerning
possible violations of fraud and abuse statutes and regulations by health care
providers.
Violations of these laws and regulations could result in expulsion from
government health care programs together with the imposition of significant
fines and penalties, as well as significant repayments for patient services
previously billed. Management believes that the Company is in compliance with
fraud and abuse as well as other applicable government laws and regulations;
however, the possibility for future governmental review and interpretation
exists.
13. Supplemental Cash Flow Information
Supplemental Disclosure of Cash Flow Information
The Company made interest payments of approximately $609,000, $1,447,000, and
$1,682,000, in the years ended September 30, 2002, 2001, and 2000, respectively.
The Company made no income tax payments in the years ended September 30, 2002,
2001, and 2000, respectively.
Supplemental Non-Cash Financing Activities
No capital lease obligations were incurred in fiscal years 2002, 2001, and 2000.
14. Realignment and Impairment Charges
At September 30, 2001, three centers were deemed to have impaired goodwill. One
center in the Columbia region and one center in the Greenville-Spartanburg
region had decreased profitability during fiscal year 2001 due to changes in the
assigned physicians. Additionally, as of September 30, 2001, a decision had been
made to combine the two Knoxville locations into one and, therefore, the
goodwill associated with the closed location was deemed to be impaired and,
therefore, was written off. The combined impairment charge for all three
locations was approximately $753,000.
Effective June 30, 2000, the Company closed its Atlanta physician practices. The
performance of these centers, which were originally acquired in May 1998, did
not meet the expectations of the Company and the Company was no longer committed
to the Georgia market. As a result of the decision to close these centers
coupled with the fact that the remaining projected undiscounted cash flows were
less than the carrying value of the long-lived assets and goodwill for these
centers, the Company recorded an impairment in the quarter ended March 31, 2000
of approximately $3,567,000 to reduce the goodwill to its fair value.
Additionally, the Company incurred costs associated with the decision to close
the Atlanta centers. These costs relate primarily to exiting certain lease
obligations and paying severance benefits to certain employees at the closed
locations. Severance costs of $185,000 and lease obligations, net of estimated
sub-lease income, of $376,000 are included in the line item Realignment and
Impairment Charges.
In addition, the Company accrued approximately $600,000 of estimated operating
lease obligations related to closed centers. The leasing obligation will be paid
over a remaining term ranging from one to fourteen years. During fiscal year
1999, the Company changed its estimated lease obligation by approximately
$329,000 when three landlords released the Company from its obligation and
during fiscal year 2000, the Company changed its estimate by $29,500 relating to
the one remaining lease obligation.
Balance at September 30, 1999 $ 162,500
Lease payments on 1998 estimate (48,000)
Change in estimated lease obligations from fiscal year 1998 29,500
Accrued lease obligations during fiscal year 2000 376,000
Accrued severance obligations during fiscal year 2000 185,000
Severance payments (185,000)
Lease payments on 2000 estimate (134,000)
----------------
Balance at September 30, 2000 $ 386,000
Change in accrued lease obligations from fiscal year 1998 (290,000)
----------------
Balance at September 30, 2001 $ 96,000
Lease payments (96,000)
----------------
Balance at September 30, 2002 $ --
================
SIGNATURES
Pursuant to the requirements of Section 13 or 15 of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Signature Title Date
/s/ D. Michael Stout, MD President and December 27, 2002
- ------------------------
D. Michael Stout, MD Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the registrant and
in the capacities and on the dates indicated.
Signature Title Date
/s/ D. Michael Stout, MD President and December 27, 2002
- ------------------------
D. Michael Stout, MD Chief Executive Officer
/s/ Jerry F. Wells, Jr., CPA Executive Vice President and December 27, 2002
- -----------------------------
Jerry F. Wells, Jr., CPA Chief Financial Officer
/s/ Harold H. Adams, Jr., CPCU Director December 27, 2002
- ------------------------------
Harold H. Adams, Jr., CPCU
/s/ Charles M. Potok Director December 27, 2002
- --------------------
Charles M. Potok
/s/ Ashby Jordan, MD Director December 27, 2002
- --------------------
Ashby Jordan, M.D.
/s/ John M. Little, Jr., MD, MBA Director December 27, 2002
- --------------------------------
John M. Little, Jr., M.D., MBA
CERTIFICATION
I, D. Michael Stout, MD, certify that:
1. I have reviewed this annual report on Form 10-K of UCI Medical
Affiliates, Inc.;
2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this annual report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
we have:
a) Designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;
b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
annual report (the "Evaluation Date"); and
c) Presented in this annual report our conclusions about the effectiveness
of the disclosure controls and procedures based on our evaluation as of
the Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons
performing the equivalent function):
a) All significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have
identified for the registrant's auditors any material weaknesses in
internal controls; and
b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
controls; and
6. The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant
deficiencies and material weaknesses.
Date: December 16, 2002 /s/ D. Michael Stout, M.D.
--------------------------
D. Michael Stout, M.D.
President & Chief Executive Officer
CERTIFICATION
I, Jerry F. Wells, Jr., CPA, certify that:
1. I have reviewed this annual report on Form 10-K of UCI Medical
Affiliates, Inc.;
2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial
information included in this Annual report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this Annual report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
we have:
a) Designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this Annual report is
being prepared;
b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
Annual report (the "Evaluation Date"); and
c) Presented in this Annual report our conclusions about the effectiveness
of the disclosure controls and procedures based on our evaluation as of
the Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons
performing the equivalent function):
a) All significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have
identified for the registrant's auditors any material weaknesses in
internal controls; and
b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
controls; and
6. The registrant's other certifying officers and I have indicated in this
Annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant
deficiencies and material weaknesses.
Date: December 16, 2002 /s/ Jerry F. Wells, Jr., CPA
-----------------------------------
Jerry F. Wells, Jr., CPA
Executive Vice President and Chief Financial Officer
UCI MEDICAL AFFILIATES, INC.
EXHIBIT INDEX
PAGE NUMBER OR INCORPORATION BY
EXHIBIT NUMBER REFERENCE TO
DESCRIPTION
- ----------------- ------------------------------------------------------- ------------------------------------
Order of Confirmation of UCI Medical Affiliates, Inc.
2.1 ("UCI") Dated August 7, 2002 Exhibit 2.1 on the Form 8-K filed
August 16, 2002
Order of Confirmation of UCI Medical Affiliates of
2.2 South Carolina Dated August 5, 2002 Exhibit 2.2 on the Form 8-K filed
August 16, 2002
Order of Confirmation of UCI Medical Affiliates of
2.3 Georgia, Inc. Dated August 7, 2002 Exhibit 2.3 on the Form 8-K filed
August 16, 2002
Order of Confirmation of Doctor's Care, P.A. Dated
2.4 August 8, 2002 Exhibit 2.4 on the Form 8-K filed
August 16, 2002
Order of Confirmation of Doctor's Care of Tennessee,
2.5 P.C. Dated August 6, 2002 Exhibit 2.5 on the Form 8-K filed
August 16, 2002
Order of Confirmation of Doctor's Care of Georgia,
2.6 P.C. Dated August 7, 2002 Exhibit 2.6 on the Form 8-K filed
August 16, 2002
Plan of Reorganization for UCI
2.7 Exhibit 2.7 on the Form 8-K filed
Plan of Reorganization for UCI Medical Affiliates of August 16, 2002
2.8 South Carolina, Inc.
Exhibit 2.8 on the Form 8-K filed
Plan of Reorganization of UCI Medical Affiliates of August 16, 2002
2.9 Georgia, Inc.
Exhibit 2.9 on the Form 8-K filed
Plan of Reorganization of Doctor's Care, P.A. August 16, 2002
2.10
Exhibit 2.10 on the Form 8-K filed
Plan of Reorganization of Doctor's Care of Tennessee, August 16, 2002
2.11 P.C.
Exhibit 2.11 on the Form 8-K filed
Plan of Reorganization for Doctor's Care of Georgia, August 16, 2002
2.12 P.C.
Exhibit 2.12 on the Form 8-K filed
Joint Disclosure Statement filed of May 3, 2002 August 16, 2002
2.13
Addendum to Joint Disclosure Statement and Plans of Exhibit 2.13 on the Form 8-K filed
2.14 Reorganization Filed as of June 14, 2002 August 16, 2002
Exhibit 2.14 on the Form 8-K filed
Second Addendum to Plans of Reorganization Filed as August 16, 2002
2.15 of July 29, 2002
Exhibit 2.15 on the Form 8-K filed
August 16, 2002
3.1 Amended and Restated Certificate of Incorporation of Exhibit 3.1 on the Form 10-K/ASB
UCI filed for fiscal year 1995
3.2 Amended and Restated Bylaws of UCI Exhibit 3.2 on the Form 10-K/ASB
filed for fiscal year 1995
PAGE NUMBER OR INCORPORATION BY
EXHIBIT NUMBER REFERENCE TO
DESCRIPTION
- ----------------- ------------------------------------------------------- ------------------------------------
- ----------------- ------------------------------------------------------- ------------------------------------
3.3 Amendment to Amended and Restated Bylaws of UCI Exhibit 3.3 on the Form 10-K/ASB
filed for fiscal year 1996
3.4 Amendment to Amended and Restated Bylaws of UCI Exhibit 3.4 on the Form 8-K filed
as of October 28, 2002
3.5 Certificate of Amendment of Certificate of 58
Incorporation
Exhibit 4.1 on the Form 10-K/ASB
4.1 Convertible Subordinated Debenture of UCI dated filed for fiscal year 1997
October 6, 1997 payable to FPA Medical Management,
Inc. ("FPAMM")
4.2 Stock Purchase Warrant Agreement dated October 6, Exhibit 4.2 on the Form 10-K/ASB
1996 between UCI and FPAMM filed for fiscal year 1997
10.1 Employment Agreement dated October 1, 1995 between Exhibit 10.4 on the Form 10-K/ASB
UCI-SC and M.F. McFarland, III, M.D. filed for fiscal year 1995
10.2 Employment Agreement dated October 1, 1995 between Exhibit 10.5 on the Form 10-K/ASB
Doctor's Care, P.A. and M.F. McFarland, III, M.D. filed for fiscal year 1995
10.3 Employment Agreement dated November 1, 1995 between Exhibit 10.6 on the Form 10-K/ASB
UCI-SC and D. Michael Stout, M.D. filed for fiscal year 1995
10.4 Employment Agreement November 1, 1995 between Exhibit 10.7 on the Form 10-K/ASB
Doctor's Care, P.A. and D. Michael Stout, M.D. filed for fiscal year 1995
10.5 Lease and License Agreement dated March 30, 1994 Exhibit 10.8 on the Form 10-K/ASB
between Doctor's Care, P.A. and Blue Cross Blue filed for fiscal year 1995
Shield of South Carolina
Exhibit 10.8 on the Form 10-K/ASB
10.6 Note Payable dated February 28, 1995 between UCI-SC, filed for fiscal year 1997
as payor, and Companion Property and Casualty
Insurance Company, as payee
Exhibit 10.9 on the Form 10-K/ASB
10.7 Revolving Line of Credit dated November 11, 1996 filed for fiscal year 1997
between Carolina First Bank and UCI
Exhibit 10.10 on the Form 10-K/ASB
10.8 Stock Option Agreement dated March 20, 1996 between filed for fiscal year 1997
UCI and Harold H. Adams, Jr.
PAGE NUMBER OR INCORPORATION BY
EXHIBIT NUMBER REFERENCE TO
DESCRIPTION
- ----------------- ------------------------------------------------------- ------------------------------------
Exhibit 10.11 on the Form 10-K/ASB
10.9 Stock Option Agreement dated March 20, 1996 between filed for fiscal year 1997
UCI and Russell J. Froneberger
Exhibit 10.12 on the Form 10-K/ASB
10.10 Stock Option Agreement dated March 27, 1997 between filed for fiscal year 1997
UCI and Charles P. Cannon
Exhibit 10.13 on the Form 10-K/ASB
10.11 Stock Option Agreement dated March 27, 1997 between filed for fiscal year 1997
UCI and Thomas G. Faulds
Exhibit 10.14 on the Form 10-K/ASB
10.12 Stock Option Agreement dated March 27, 1997 between filed for fiscal year 1997
UCI and Ashby Jordan, M.D.
Exhibit 10.15 on the Form 10-K/ASB
10.13 Stock Option Agreement dated March 27, 1997 between filed for fiscal year 1997
UCI and Charles M. Potok
10.14 UCI 1994 Incentive Stock Option Plan Exhibit 10.9 on the Form 10-K/ASB
filed for fiscal year 1995
10.15 Consulting Agreement dated December 10, 1996 between Exhibit 10.17 on the Form 10-K/ASB
UCI and Global Consulting, Inc. filed for fiscal year 1997
10.16 Amendment dated August 10, 1998 to Employment Exhibit 10.18 on the Form 10-K/ASB
Agreement dated October 6, 1995 between Doctor's filed for fiscal year 1998
Care, P.A. and M.F. McFarland, III, M.D.
10.17 Administrative Services Agreement dated April 24, Exhibit 10.19 on the Form 10-QSB
1998 by and between Doctor's Care of Georgia, P.C. filed for the quarter ended March
and UCI Medical Affiliates of Georgia, Inc. 31, 1998
10.18 Administrative Services Agreement dated April 24, Exhibit 10.20 on the Form 10-QSB
1998 by and between Doctor's Care of Tennessee, P.C. filed for the quarter ended March
and UCI Medical Affiliates of Tennessee, Inc. 31, 1998
10.19 Administrative Services Agreement dated August 11, Exhibit 10.21 on the Form 10-K/ASB
1998 between UCI Medical Affiliates of South filed for fiscal year 1997
Carolina, Inc. and Doctor's Care, P.A.
10.20 Stock Purchase Option and Restriction Agreement dated Exhibit 10.22 on the Form 10-K/ASB
August 11, 1998 by and among M.F. McFarland, III, filed for fiscal year 1998
M.D.; UCI Medical Affiliates of South Carolina, Inc.;
and Doctor's Care, P.A.
10.21 Stock Purchase Option and Restriction Agreement dated Exhibit 10.23 on the Form 10-K/ASB
September 1, 1998 by and among D. Michael Stout, filed for fiscal year 1998
M.D.; UCI Medical Affiliates of Georgia, Inc.; and
Doctor's Care of Georgia, P.C.
10.22 Stock Purchase Option and Restriction Agreement dated Exhibit 10.24 on the Form 10-K/ASB
July 15, 1998 by and among D. Michael Stout, M.D.; filed for fiscal year 1998
UCI Medical Affiliates of Georgia, Inc.; and Doctor's
Care of Tennessee, P.C.
PAGE NUMBER OR INCORPORATION BY
EXHIBIT NUMBER REFERENCE TO
DESCRIPTION
- ----------------- ------------------------------------------------------- ------------------------------------
10.23 Acquisition Agreement and Plan of Reorganization Exhibit 2 on the Form 8-K filed
dated February 9, 1998, by and among UCI Medical February 17, 1998
Affiliates of Georgia, Inc., UCI Medical Affiliates,
Inc., MainStreet Healthcare Corporation; MainStreet
Healthcare Medical Group, P.C.; MainStreet Healthcare
Medical Group, P.C.; Prompt Care Medical Center,
Inc.; Michael J. Dare; A. Wayne Johnson; Penman
Private Equity and Mezzanine Fund, L.P.; and Robert
G. Riddett, Jr.
10.24 First Amendment to Acquisition Agreement and Plan of Exhibit 2.1 on Form 8-K/A filed
Reorganization (included as Exhibit 10.25 hereof) April 20, 1998
dated April 15, 1998.
10.25 Second Amendment to Acquisition Agreement and Plan of Exhibit 2.2 on Form 8-K/A filed
Reorganization (included as Exhibit 10.25 hereof) May 28, 1998
dated May 7, 1998.
10.26 Conditional Delivery Agreement dated effective as of Exhibit 2.3 on Form 8-K/A filed
May 1, 1998, by and among UCI Medical Affiliates, July 24, 1998
Inc.; UCI Medical Affiliates of Georgia, Inc.; and
MainStreet Healthcare Corporation.
10.27 Amendment to Conditional Delivery Agreement dated as Exhibit 2.4 on Form 8-K/A filed
of July 21, 1998, by and among UCI Medical July 24, 1998
Affiliates, Inc.; UCI Medical Affiliates of Georgia,
Inc.; and MainStreet Healthcare Corporation.
10.28 Second Amendment to Conditional Delivery Agreement Exhibit 2.5 on Form 8-K/A filed on
dated as of December 7, 1998, by and among UCI December 7, 1998
Medical Affiliates, Inc.; UCI Medical Affiliates of
Georgia, Inc.; and MainStreet Healthcare Corporation.
10.29 Amended Employment Agreement dated August 19, 1999 Exhibit 10.31 on Form 10-K/A filed
between UCI Medical Affiliates of South Carolina, for fiscal year 1999
Inc. and M.F. McFarland, III, M.D.
10.30 Second Amended Employment Agreement dated August 19, Exhibit 10.32 on Form 10-K/A filed
1999 between Doctor's Care, P.A. and M.F. McFarland, for fiscal year 1999
III, M.D.
10.31 Stock Purchase Option and Restriction Agreement dated 59
as of October 31, 2002 by and among D. Michael Stout,
MD; UCI Medical Affiliates of South Carolina, Inc.;
and Doctor's Care, P.A.
21 Subsidiaries of the Registrant Exhibit 21 on the Form 10-QSB
filed for period ending December
31, 1997
63
99.1 Certification Pursuant to 18 U.S.C. Section 1350, as
adopted Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
64
99.2 Certification Pursuant to 18 U.S.C. Section 1350, as
adopted Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
EXHIBIT 3.5
STATE of DELAWARE
CERTIFICATE of AMENDMENT of CERTIFICATE of INCORPORATION
of
UCI MEDICAL AFFILIATES, INC.
First: That the Board of Directors of UCI Medical Affiliates, Inc. by
unanimous consent in writing adopted resolutions setting forth a proposed
amendment of the Amended and Restated Certificate of Incorporation of said
corporation, declaring said amendment to be advisable and calling a meeting of
the stockholders of said corporation for consideration thereof. The resolution
setting forth the proposed amendment is as follows:
RESOLVED, that the first paragraph of the Article numbered FOURTH of
the Amended and Restated Certificate of Incorporation of this
corporation is amended so as to read in its entirety as follows:
FOURTH: The total number of shares of stock which the
corporation shall have authority to issue is as follows: Fifty
Million (50,000,000) shares of Common Stock, having a par
value of five cents ($0.05) per share, amounting in the
aggregate to Two Million Five Hundred Thousand Dollars
($2,500,000), and Ten Million (10,000,000) shares of Preferred
Stock having a par value of one cent ($0.01) per share,
amounting in the aggregate to One Hundred Thousand Dollars
($100,000).
Second: That thereafter, pursuant to resolution of its Board of
Directors, a meeting of the stockholders of said corporation was duly called and
held, upon notice in accordance with Section 222 of the General Corporation Law
of the State of Delaware at which meeting the necessary number of shares as
required by statute were voted in favor of the amendment.
Third: That said amendment was duly adopted in accordance with the
provisions of Section 242 of the General Corporation Law of the State of
Delaware.
Fourth: That the capital of said corporation shall not be reduced under or
by reason of said amendment.
In Witness Whereof, said UCI Medical Affiliates, Inc. has caused this
certificate to be signed by M. F. McFarland, III, M.D., its President, and
attested by Jerry F. Wells, Jr., its Secretary, this 24th day of February, A.D.
1999.
UCI MEDICAL AFFILIATES, INC.
By: /s/ M.F. McFarland, III, M.D.
M.F. McFarland, III, M.D.
President
Attest: /s/ Jerry F. Wells, Jr.
Jerry F. Wells, Jr.
Secretary
EXHIBIT 10.31
STOCK PURCHASE OPTION AND RESTRICTION AGREEMENT
THIS STOCK PURCHASE OPTION AND RESTRICTION AGREEMENT (the "Option") is made
as of this 21st day of November, 2002, to be effective as of October 31, 2002,
by and among D. Michael Stout, M.D. (the "Shareholder"), UCI Medical Affiliates
of South Carolina, Inc., a South Carolina corporation ("UCI of SC"), and
Doctor's Care, P.A., a South Carolina professional corporation (the "Company").
WHEREAS, effective as of October 31, 2002, M. F. McFarland, III, M.D.
("McFarland") sold to the Shareholder 900 of the issued and outstanding shares
(the "Shares") of the common stock of the Company, pursuant to the direction of
UCI of SC under that certain Stock Purchase Option and Restriction Agreement by
and among the Company, UCI of SC, and McFarland dated August 11, 1998;
WHEREAS, in connection with the above-described sale of stock, UCI of
SC requires that the Shareholder grant this Option pursuant to which UCI of SC
may require that the Shareholder offer to sell any and all shares of the common
stock of the Company owned by Shareholder, including but not limited to the
Shares, to a person or persons selected by UCI of SC in accordance with the
terms and conditions set forth herein; and
WHEREAS, the Shareholder is the sole shareholder of the Company, and
the Shares represent all the issued and outstanding capital stock of the
Company.
NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are acknowledged, the Shareholder hereby irrevocably grants
unto UCI of SC and its successors and assigns (the "Option holder") an option to
the person or persons selected by the Option holder (the "Purchaser") to
purchase any and all shares of the common stock of the Company now or hereafter
owned by Shareholder, including but not limited to the Shares, at the price and
upon the terms and conditions described herein, exercisable upon presentation of
this Option and payment of the purchase price as follows:
1. Option Share: Shareholder represents and warrants that: (a) as of
the date hereof, the Shares constitute all the issued and outstanding shares of
stock or other securities held directly or indirectly by Shareholder in the
Company; and (b) Shareholder owns, and shall deliver at the closing (as
described below), the Shares free and clear of all of pledges, options, security
interests, liens, claims, or other encumbrances whatsoever and has full right,
power, and authority to option and transfer the Shares as described herein.
2. Exercise Price: Exercise of this Option requires the payment of One
Hundred and No/100 ($100.00) Dollars in cash or personal check by the Purchaser
to the Shareholder (the "Exercise Price").
3. Option Period: This Option shall expire, and the Shareholder's
restrictions hereunder shall terminate, upon the earlier of (i) three years
after the effective date of the dissolution of the Company, unless the Company
is earlier reinstated pursuant to the South Carolina Business Corporation Code,
as amended, in which event this Option shall not terminate; or (ii) the
consummation of the exercise of this Option as set forth herein; or (iii) the
written consent of UCI of SC.
4. Option Exercise: The Option holder may exercise this Option by
providing written notice (an "Exercise Notice") indicating the name of the
Purchaser(s), to the Shareholder at the Shareholder's notice address set forth
below, whereupon closing of the purchase of the Share shall take place at the
date set forth in the Exercise Notice (but not sooner than one (1) day nor later
than ten (10) days after the date the Exercise Notice is delivered to the
Shareholder), or at such other date as the Purchaser and the Shareholder shall
agree. Closing shall take place at the principal office of UCI of SC in
Columbia, South Carolina, or at such other place as the Option holder and the
Shareholder shall agree. The purchase of the Shares pursuant to this Option
shall be effective for all purposes at the time the Purchaser tenders payment to
the Shareholder of the Exercise Price.
5. Transfer Upon Exercise: Upon delivery to the Shareholder of the
Exercise Notice by the Option holder, the Shareholder (or in the event of the
Shareholder's death, the personal representative of Shareholder) shall timely
deliver or cause to be delivered to the Purchaser on the date and at the place
of closing set forth in the Exercise Notice such stock certificates and stock
powers, duly endorsed for transfer, as are necessary to complete the transfer of
the Shares to Purchaser. Upon delivery to the Purchaser of such instruments, the
Purchaser shall immediately pay the Exercise Price to the Shareholder.
6. Restrictions on Shares: So long as this Option remains outstanding,
(a) the Shareholder shall retain full title to, and reserve for the benefit of
the Option holder, the Shares; (b) certificates representing the Shares shall
bear an appropriate legend reflecting the Option holder's rights under this
Option; and (c) the Shareholder shall not transfer the Shares except pursuant to
this Option without the Option holder's prior written consent which may be
withheld for any or no reason. Any transfer in violation of this Section shall
be null, void, and without effect. The Shareholder hereby acknowledges that the
restrictions set forth in this Section are necessary to maintain the number and
identity of the shareholders of the Company and are not manifestly unreasonable.
Each certificate evidencing shares of stock of the Company now or hereafter held
by the Shareholder shall bear a conspicuous statement in substantially the
following form:
THE SHARES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO THAT
CERTAIN STOCK PURCHASE OPTION AND RESTRICTION AGREEMENT (THE
"OPTION"), A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF
THE COMPANY. ANY PURPORTED TRANSFER OR DISPOSITION OF SUCH
SHARES IN VIOLATION OF THE OPTION SHALL BE COMPLETELY NULL AND
VOID.
7. Voting and Other Shareholder Rights: Option holder shall have none
of the voting or other rights of a shareholder with respect to the Share which
are the subject of this Option granted hereby until such Share has been fully
paid for upon valid exercise of this Option.
8. Anti-Dilution Features: In the event that the Company proposes,
while this Option remains outstanding, (a) to make a stock dividend, stock
distribution, stock split, reverse stock split, stock reclassification, or (b)
to undergo a recapitalization, merger, consolidation, share exchange, or sale of
all or substantially all assets in return for securities of another company, the
Exercise Price and/or the number of shares subject to this Option shall be
adjusted equitably so that the Option holder shall be entitled to require that
the Shareholder transfer to the Purchaser appointed by the Option holder for a
proportionate aggregate price an equity and economic position in the Company
consistent with the equity and economic position in the Company available under
this Option at the date hereof. Notwithstanding anything contained herein to the
contrary, in the event for any reason the Shareholder is the owner of multiple
shares of the capital stock of the Company, the term "Shares" as used herein
shall be deemed to include any and all such shares of the capital stock of the
Company owned by Shareholder from time to time.
9. Resignation: The Shareholder shall be deemed to have resigned as an
officer and director of the Company at the time the Purchaser tenders payment to
the Shareholder of the Exercise Price as set forth in Section 4.
10. License to Practice Medicine: The Shareholder hereby represents and
warrants that as of the date hereof Shareholder is licensed to practice medicine
in the State of South Carolina.
11. Notice of Certain Events: So long as this Option has not expired or
been terminated pursuant to Section 3 hereof, (i) if the Company shall desire to
amend its bylaws or its Articles of Incorporation; or (ii) if any capital
reorganization of the Company, reclassification of the capital stock of the
Company, consolidation or merger of the Company with or into another
corporation, sale lease, or transfer of all or substantially all of the property
and assets of the Company shall desire to be effected; or (iii) if the Company
shall desire to pay any dividend, in shares of stock or cash or otherwise, or
make any distribution upon the shares of its capital stock, then in any such
case, the Company shall cause to be delivered to the Option holder, at least
thirty (30) days prior to the record date fixed for the purpose of determining
shareholders entitled to vote on such action, or to receive such dividend,
distribution, or offer, or to receive shares or other assets deliverable upon
such reorganization, reclassification, consolidation, merger, sale, lease,
transfer, dissolution, liquidation, or winding up, as the case may be, a notice
containing a brief description of the proposed action and stating such record
date.
12. Specific Performance: Each party hereto acknowledges and agrees
that the other parties hereto would be damaged irreparably in the event any of
the provisions of this Option are not performed in accordance with their
specific terms or otherwise breached. Accordingly, each party agrees that the
other parties hereto shall be entitled to an injunction or injunctions to
prevent breaches of the provisions of this Option and to specifically enforce
this Option and the terms and provisions hereof in any action instituted in any
court of the United States of any state thereof having jurisdiction over the
parties and the matter, in addition to any other remedy to which it may be
entitled, at law or in equity.
13. Miscellaneous: The Option holder shall be entitled to assign this
Option to any person or other entity, including but not limited to any
corporation controlled by or under common control with the Option holder, or in
connection with the acquisition of, or the sale of substantially all of, the
assets of the Option holder. This option may not be assigned by Shareholder
without the prior written consent of the Option holder. This Option shall inure
to the benefit of the Option holder and its successors and assigns and shall be
binding upon the Shareholder and his heirs and permitted assigns. This Option
may be modified or amended, and rights and obligations hereunder may be waived,
only in writing, signed by the Option holder and the Shareholder. This Option
shall be governed by and construed in accordance with the laws of the State of
South Carolina. The parties consent to jurisdiction and venue for any dispute
arising hereunder in the courts for Richland County, South Carolina. All terms
and provisions of this Option shall be severable from all other terms and
provisions of this Option. Notices required or permitted hereunder must be in
writing and shall be deemed given when placed in the U.S. certified mail, return
receipt requested, with postage prepaid, addressed to the recipient at the
notice address set forth below, or when personally delivered to the recipient.
[SIGNATURE PAGE ATTACHED]
IN WITNESS WHEREOF, the parties hereto have executed this Stock
Purchase Option and Restriction Agreement under seal to be legally binding and
effective this 31st day of October, 2002.
Notice Addresses: SHAREHOLDER:
- ---------------- -----------
4416 Forest Drive
Columbia, SC 29206 /s/ D. Michael Stout, M.D.
--------------------------
D. Michael Stout, M.D.
UCI OF SC:
---------
UCI MEDICAL AFFILIATES OF SOUTH CAROLINA, INC.
4416 Forest Drive
Columbia, South Carolina 29206 By: /s/ Jerry F. Wells, Jr.
-----------------------
Attn: Jerry F. Wells, Jr. Jerry F. Wells, Jr.
Its: Executive Vice-President and CFO
COMPANY:
DOCTOR'S CARE, P.A.
4416 Forest Drive
Columbia, South Carolina 29201 By: /s/ Jerry F. Wells, Jr.
-----------------------
Attn: Jerry F. Wells, Jr. Jerry F. Wells, Jr.
Its: Secretary
EXHIBIT 99.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of UCI Medical Affiliates, Inc.
(the "Company) on Form 10-K for the period ending September 30, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, D. Michael Stout, M.D., President and Chief Executive Officer of the Company,
certify to the best of my knowledge, pursuant to 18 U.S.C. section 1350, as
adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002 that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and 2. The information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
December 16, 2002 /s/ D. Michael Stout, M.D.
--------------------------
D. Michael Stout, M.D.
President and Chief Executive Officer
EXHIBIT 99.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of UCI Medical Affiliates, Inc.
(the "Company) on Form 10-K for the period ending September 30, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Jerry F. Wells, Jr., Executive Vice President and Chief Financial Officer of
the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. section
1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002 that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and 2. The information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
December 16, 2002 /s/ Jerry F. Wells, Jr.
-----------------------
Jerry F. Wells, Jr.
Executive Vice President
and Chief Financial Officer